| Year |
Citation |
Score |
| 2023 |
Santos E, Clark C, Biag HMB, Tang SJ, Kim K, Ponzini MD, Schneider A, Giulivi C, Montanaro FAM, Gipe JT, Dayton J, Randol JL, Yao PJ, Manolopoulos A, Kapogiannis D, ... ... Hagerman R, et al. Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS). Cells. 12. PMID 38132093 DOI: 10.3390/cells12242773 |
0.591 |
|
| 2023 |
Hessl D, Mandujano Rojas K, Ferrer E, Espinal G, Famula J, Schneider A, Hagerman R, Tassone F, Rivera SM. FMR1 Carriers Report Executive Function Changes Prior to Fragile X-Associated Tremor/Ataxia Syndrome: A Longitudinal Study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38124331 DOI: 10.1002/mds.29695 |
0.714 |
|
| 2023 |
Mei L, Hu C, Li D, Wang Y, Li H, Zhang K, Zhou B, Zhu R, Hagerman RJ, Xu X, Xu Q. Corrigendum: The incidence and clinical characteristics of fragile X syndrome in China. Frontiers in Pediatrics. 11: 1296110. PMID 37920795 DOI: 10.3389/fped.2023.1296110 |
0.302 |
|
| 2023 |
Tassone F, Protic D, Allen EG, Archibald AD, Baud A, Brown TW, Budimirovic DB, Cohen J, Dufour B, Eiges R, Elvassore N, Gabis LV, Grudzien SJ, Hall DA, Hessl D, ... ... Hagerman RJ, et al. Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on Premutation. Cells. 12. PMID 37759552 DOI: 10.3390/cells12182330 |
0.656 |
|
| 2023 |
Aishworiya R, Tak YE, Ponzini MD, Biag HMB, Salcedo-Arellano MJ, Kim K, Tassone F, Schneider A, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Lippe S, Hagerman P, ... Hagerman R, et al. Adaptive, behavioral, and cognitive outcomes in individuals with fragile X syndrome with varying autism severity. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. PMID 37724826 DOI: 10.1002/jdn.10299 |
0.707 |
|
| 2023 |
Zafarullah M, Li J, Salemi MR, Phinney BS, Durbin-Johnson BP, Hagerman R, Hessl D, Rivera SM, Tassone F. Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS. International Journal of Molecular Sciences. 24. PMID 37686279 DOI: 10.3390/ijms241713477 |
0.596 |
|
| 2023 |
Acero-Garcés DO, Saldarriaga W, Cabal-Herrera AM, Rojas CA, Hagerman RJ. Fragile X Syndrome in children. Colombia Medica (Cali, Colombia). 54: e4005089. PMID 37664646 DOI: 10.25100/cm.v54i2.5089 |
0.414 |
|
| 2023 |
Berry-Kravis E, Abbeduto L, Hagerman R, Coffey CS, Cudkowicz M, Erickson CA, McDuffie A, Hessl D, Ethridge LE, Tassone F, Kaufmann WE, Friedmann K, Bullard L, Hoffmann A, Veenstra-VanderWeele J, et al. Effects of AFQ056 on language learning in fragile X syndrome. The Journal of Clinical Investigation. PMID 37651202 DOI: 10.1172/JCI171723 |
0.572 |
|
| 2023 |
Aishworiya R, Biag HMB, Salcedo-Arellano MJ, Musa Z, Schneider A, Clark C, Santos E, Tassone F, Hagerman R. Fragile X Syndrome and Fetal Alcohol Syndrome: Occurrence of Dual Diagnosis in a Set of Triplets. Journal of Developmental and Behavioral Pediatrics : Jdbp. PMID 37556593 DOI: 10.1097/DBP.0000000000001204 |
0.578 |
|
| 2023 |
Aishworiya R, Chi MH, Zafarullah M, Mendoza G, Ponzini MD, Kim K, Biag HMB, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Jacquemont S, Lippé S, Hagerman P, ... Hagerman R, et al. Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells. 12. PMID 37508583 DOI: 10.3390/cells12141920 |
0.68 |
|
| 2023 |
Aishworiya R, Hwang YH, Santos E, Hayward B, Usdin K, Durbin-Johnson B, Hagerman R, Tassone F. Clinical implications of somatic allele expansion in female FMR1 premutation carriers. Scientific Reports. 13: 7050. PMID 37120588 DOI: 10.1038/s41598-023-33528-x |
0.376 |
|
| 2023 |
Mei L, Hu C, Li D, Wang Y, Li H, Zhang K, Zhou B, Zhu R, Hagerman RJ, Xu X, Xu Q. The incidence and clinical characteristics of fragile X syndrome in China. Frontiers in Pediatrics. 11: 1064104. PMID 36861076 DOI: 10.3389/fped.2023.1064104 |
0.379 |
|
| 2022 |
Trajković J, Makevic V, Pesic M, Pavković-Lučić S, Milojevic S, Cvjetkovic S, Hagerman R, Budimirovic DB, Protic D. as a Model to Study Fragile X-Associated Disorders. Genes. 14. PMID 36672829 DOI: 10.3390/genes14010087 |
0.405 |
|
| 2022 |
Aishworiya R, Protic D, Tang SJ, Schneider A, Tassone F, Hagerman R. Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers. Genes. 13. PMID 36553666 DOI: 10.3390/genes13122399 |
0.626 |
|
| 2022 |
Tang SJ, Giri S, Pahlavan N, Han SH, Santos ER, Espinal G, Aishworiya R, Schneider A, Hessl D, Rivera SM, Hagerman RJ. Tophaceous gout of the nose in a male premutation carrier. Clinical Case Reports. 10: e6586. PMID 36447664 DOI: 10.1002/ccr3.6586 |
0.712 |
|
| 2022 |
Berry-Kravis E, Hagerman R, Budimirovic D, Erickson C, Heussler H, Tartaglia N, Cohen J, Tassone F, Dobbins T, Merikle E, Sebree T, Tich N, Palumbo JM, O'Quinn S. A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX). Journal of Neurodevelopmental Disorders. 14: 56. PMID 36434514 DOI: 10.1186/s11689-022-09466-6 |
0.355 |
|
| 2022 |
Tosin MHS, Stebbins GT, Goetz CG, Hagerman RJ, Hessl D, Zolecki MA, Todd PK, Leehey MA, Hall DA. Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach. Frontiers in Neurology. 13: 977380. PMID 36188408 DOI: 10.3389/fneur.2022.977380 |
0.601 |
|
| 2022 |
Dy ABC, Tanchanco LBS, Sy JCY, Levantino MD, Hagerman RJ. Screening for Fragile X Syndrome Among Filipino Children with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 35972625 DOI: 10.1007/s10803-022-05707-8 |
0.346 |
|
| 2022 |
Tassanakijpanich N, Wright R, Tassone F, Shankar SP, Hagerman R. Fragile X syndrome in a girl with variant Turner syndrome and an isodicentric X chromosome. Bmj Case Reports. 15. PMID 35882436 DOI: 10.1136/bcr-2021-247901 |
0.412 |
|
| 2022 |
Albizua I, Charen K, Shubeck L, Talboy A, Berry-Kravis E, Kaufmann WE, Stallworth JL, Drazba KT, Erickson CA, Sweeney JA, Tartaglia N, Warren SF, Hagerman R, Sherman SL, Warren ST, et al. Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Molecular Genetics & Genomic Medicine. e2001. PMID 35852003 DOI: 10.1002/mgg3.2001 |
0.332 |
|
| 2022 |
Aishworiya R, Protic D, Hagerman R. Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications. Journal of Neurology. PMID 35723724 DOI: 10.1007/s00415-022-11209-5 |
0.396 |
|
| 2022 |
McLennan YA, Mosconi MW, McKenzie FJ, Famula J, Krawchuk B, Kim K, Clark CJ, Hessl D, Rivera SM, Simon TJ, Tassone F, Hagerman RJ. Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression. Movement Disorders Clinical Practice. 9: 473-478. PMID 35586536 DOI: 10.1002/mdc3.13449 |
0.6 |
|
| 2022 |
Famula J, Ferrer E, Hagerman RJ, Tassone F, Schneider A, Rivera SM, Hessl D. Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome. Journal of Neurodevelopmental Disorders. 14: 23. PMID 35321639 DOI: 10.1186/s11689-022-09436-y |
0.715 |
|
| 2022 |
Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, et al. Corrigendum: EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Frontiers in Psychiatry. 13: 867000. PMID 35280176 DOI: 10.3389/fpsyt.2022.867000 |
0.678 |
|
| 2022 |
Protic DD, Aishworiya R, Salcedo-Arellano MJ, Tang SJ, Milisavljevic J, Mitrovic F, Hagerman RJ, Budimirovic DB. Fragile X Syndrome: From Molecular Aspect to Clinical Treatment. International Journal of Molecular Sciences. 23. PMID 35216055 DOI: 10.3390/ijms23041935 |
0.384 |
|
| 2022 |
Wang JY, Grigsby J, Placido D, Wei H, Tassone F, Kim K, Hessl D, Rivera SM, Hagerman RJ. Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation. Frontiers in Neurology. 13: 797649. PMID 35211082 DOI: 10.3389/fneur.2022.797649 |
0.663 |
|
| 2022 |
Johnson D, Santos E, Kim K, Ponzini MD, McLennan YA, Schneider A, Tassone F, Hagerman RJ. Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome. Frontiers in Psychiatry. 12: 762915. PMID 35126193 DOI: 10.3389/fpsyt.2021.762915 |
0.45 |
|
| 2022 |
Gürkan CK, Hagerman RJ. TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME. Research in Autism Spectrum Disorders. 6: 1311-1320. PMID 23162607 DOI: 10.1016/j.rasd.2012.05.007 |
0.412 |
|
| 2021 |
Sodhi DK, Hagerman R. Fragile X Premutation: Medications, Therapy and Lifestyle Advice. Pharmacogenomics and Personalized Medicine. 14: 1689-1699. PMID 35002287 DOI: 10.2147/PGPM.S338846 |
0.389 |
|
| 2021 |
Protic D, Salcedo-Arellano MJ, Stojkovic M, Saldarriaga W, Ávila Vidal LA, Miller RM, Tabatadze N, Peric M, Hagerman R, Budimirovic DB. Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries? The Yale Journal of Biology and Medicine. 94: 559-571. PMID 34970093 |
0.305 |
|
| 2021 |
Salcedo-Arellano MJ, Hagerman RJ. Recent research in fragile X-associated tremor/ataxia syndrome. Current Opinion in Neurobiology. 72: 155-159. PMID 34890957 DOI: 10.1016/j.conb.2021.11.006 |
0.408 |
|
| 2021 |
Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, et al. EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Frontiers in Psychiatry. 12: 716707. PMID 34858220 DOI: 10.3389/fpsyt.2021.716707 |
0.672 |
|
| 2021 |
Roth M, Ronco L, Cadavid D, Durbin-Johnson B, Hagerman RJ, Tassone F. FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability. Diagnostics (Basel, Switzerland). 11. PMID 34679478 DOI: 10.3390/diagnostics11101780 |
0.336 |
|
| 2021 |
Salcedo-Arellano MJ, Sanchez D, Wang JY, McLennan YA, Clark CJ, Juarez P, Schneider A, Tassone F, Hagerman RJ, Martínez-Cerdeño V. Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome. Frontiers in Neuroscience. 15: 720253. PMID 34602969 DOI: 10.3389/fnins.2021.720253 |
0.547 |
|
| 2021 |
Hagerman RJ, Hagerman PJ. Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon. Annual Review of Pharmacology and Toxicology. PMID 34499526 DOI: 10.1146/annurev-pharmtox-052120-090147 |
0.359 |
|
| 2021 |
Tassanakijpanich N, McKenzie F, McLennan YA, Makhoul E, Tassone F, Jasoliya MJ, Romney C, Petrasic IC, Napalinga K, Buchanan CB, Hagerman P, Hagerman R, Casanova EL. Hypermobile Ehlers-Danlos syndrome (hEDS) phenotype in fragile X premutation carriers: case series. Journal of Medical Genetics. PMID 34193467 DOI: 10.1136/jmedgenet-2020-107609 |
0.316 |
|
| 2021 |
Napoli E, Flores A, Mansuri Y, Hagerman RJ, Giulivi C. Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome. Neurobiology of Disease. 105427. PMID 34153466 DOI: 10.1016/j.nbd.2021.105427 |
0.34 |
|
| 2021 |
Hagerman R, Hagerman P. Fragile X-associated tremor/ataxia syndrome: pathophysiology and management. Current Opinion in Neurology. PMID 33990099 DOI: 10.1097/WCO.0000000000000954 |
0.338 |
|
| 2021 |
Salcedo-Arellano MJ, Wang JY, McLennan YA, Doan M, Cabal-Herrera AM, Jimenez S, Wolf-Ochoa MW, Sanchez D, Juarez P, Tassone F, Durbin-Johnson B, Hagerman RJ, Martínez-Cerdeño V. Cerebral Microbleeds in Fragile X-Associated Tremor/Ataxia Syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33760253 DOI: 10.1002/mds.28559 |
0.397 |
|
| 2021 |
Hagerman PJ, Hagerman R. Fragile X syndrome. Current Biology : Cb. 31: R273-R275. PMID 33756134 DOI: 10.1016/j.cub.2021.01.043 |
0.427 |
|
| 2021 |
Saldarriaga-Gil W, Cabal-Herrera AM, Fandiño-Losada A, Vásquez A, Hagerman R, Tassone F. Inequities in diagnosis of Fragile X syndrome in Colombia. Journal of Applied Research in Intellectual Disabilities : Jarid. PMID 33538083 DOI: 10.1111/jar.12863 |
0.386 |
|
| 2021 |
Tassanakijpanich N, Hagerman RJ, Worachotekamjorn J. Fragile X premutation and associated health conditions: A review. Clinical Genetics. PMID 33443313 DOI: 10.1111/cge.13924 |
0.399 |
|
| 2020 |
Salcedo-Arellano MJ, Cabal-Herrera AM, Punatar RH, Clark CJ, Romney CA, Hagerman RJ. Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33215285 DOI: 10.1007/s13311-020-00968-6 |
0.334 |
|
| 2020 |
Napoli E, McLennan YA, Schneider A, Tassone F, Hagerman RJ, Giulivi C. Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked Gene. Frontiers in Molecular Biosciences. 7: 578640. PMID 33195422 DOI: 10.3389/fmolb.2020.578640 |
0.569 |
|
| 2020 |
Rajaratnam A, Potter LA, Biag HMB, Schneider A, Petrasic IC, Hagerman RJ. Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment. Frontiers in Neurology. 11: 581429. PMID 33193037 DOI: 10.3389/fneur.2020.581429 |
0.59 |
|
| 2020 |
Schneider A, Summers S, Tassone F, Seritan A, Hessl D, Hagerman P, Hagerman R. Women with Fragile X-associated Tremor/Ataxia Syndrome. Movement Disorders Clinical Practice. 7: 910-919. PMID 33163562 DOI: 10.1002/Mdc3.13084 |
0.764 |
|
| 2020 |
Tassanakijpanich N, Cohen J, Cohen R, Srivatsa UN, Hagerman RJ. Cardiovascular Problems in the Fragile X Premutation. Frontiers in Genetics. 11: 586910. PMID 33133171 DOI: 10.3389/fgene.2020.586910 |
0.353 |
|
| 2020 |
Hall DA, Leehey MA, Hagerman RJ, Pelak VS. Eye Movements in Fragile X-Associated Tremor/Ataxia Syndrome. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. PMID 33110011 DOI: 10.1097/WNO.0000000000001082 |
0.359 |
|
| 2020 |
Saldarriaga W, Payán-Gómez C, González-Teshima LY, Rosa L, Tassone F, Hagerman RJ. Double Genetic Hit: Fragile X Syndrome and Partial Deletion of Protein Patched Homolog 1 Antisense as Cause of Severe Autism Spectrum Disorder. Journal of Developmental and Behavioral Pediatrics : Jdbp. PMID 32947579 DOI: 10.1097/DBP.0000000000000850 |
0.385 |
|
| 2020 |
Luu S, Province H, Berry-Kravis E, Hagerman R, Hessl D, Vaidya D, Lozano R, Rosselot H, Erickson C, Kaufmann WE, Budimirovic DB. Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis. Brain Sciences. 10. PMID 32932789 DOI: 10.3390/Brainsci10090629 |
0.645 |
|
| 2020 |
McKinney WS, Bartolotti J, Khemani P, Wang JY, Hagerman RJ, Mosconi MW. Cerebellar-cortical function and connectivity during sensorimotor behavior in aging FMR1 gene premutation carriers. Neuroimage. Clinical. 27: 102332. PMID 32711390 DOI: 10.1016/J.Nicl.2020.102332 |
0.303 |
|
| 2020 |
Berry-Kravis E, Horrigan JP, Tartaglia N, Hagerman R, Kolevzon A, Erickson CA, Hatti S, Snape M, Yaroshinsky A, Stoms G, Glass L, Jones NE. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome. Pediatric Neurology. PMID 32660869 DOI: 10.1016/j.pediatrneurol.2020.04.019 |
0.338 |
|
| 2020 |
Schneider A, Winarni TI, Cabal-Herrera AM, Bacalman S, Gane L, Hagerman P, Tassone F, Hagerman R. Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations. Translational Psychiatry. 10: 205. PMID 32576818 DOI: 10.1038/S41398-020-00863-W |
0.652 |
|
| 2020 |
Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, Hagerman RJ. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications. International Journal of Molecular Sciences. 21. PMID 32575683 DOI: 10.3390/ijms21124391 |
0.43 |
|
| 2020 |
Jasoliya M, Bowling H, Petrasic IC, Durbin-Johnson B, Klann E, Bhattacharya A, Hagerman R, Tassone F. Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome. Brain Sciences. 10. PMID 32531912 DOI: 10.3390/Brainsci10060361 |
0.405 |
|
| 2020 |
Cabal-Herrera AM, Saldarriaga-Gil W, Salcedo-Arellano MJ, Hagerman RJ. Fragile X associated neuropsychiatric disorders in a male without FXTAS. Intractable & Rare Diseases Research. 9: 113-118. PMID 32494560 DOI: 10.5582/irdr.2020.01028 |
0.4 |
|
| 2020 |
Salcedo-Arellano MJ, Cabal-Herrera AM, Tassanakijpanich N, McLennan YA, Hagerman RJ. Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series. Biomedicines. 8. PMID 32466255 DOI: 10.3390/biomedicines8050136 |
0.381 |
|
| 2020 |
Salcedo-Arellano MJ, Wolf-Ochoa MW, Hong T, Amina S, Tassone F, Lechpammer M, Hagerman R, Martínez-Cerdeño V. Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome. Movement Disorders Clinical Practice. 7: 413-418. PMID 32373658 DOI: 10.1002/Mdc3.12942 |
0.459 |
|
| 2020 |
Alolaby RR, Jiraanont P, Durbin-Johnson B, Jasoliya M, Tang HT, Hagerman R, Tassone F. Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder. Frontiers in Genetics. 11: 308. PMID 32346385 DOI: 10.3389/Fgene.2020.00308 |
0.373 |
|
| 2020 |
Thurman AJ, Potter LA, Kim K, Tassone F, Banasik A, Potter SN, Bullard L, Nguyen V, McDuffie A, Hagerman R, Abbeduto L. Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome. Journal of Neurodevelopmental Disorders. 12: 12. PMID 32316911 DOI: 10.1186/S11689-020-09315-4 |
0.377 |
|
| 2020 |
Hill EJ, Goetz CG, Stebbins GT, Hagerman R, Ouyang B, Hall DA. Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome. Movement Disorders Clinical Practice. 7: 298-302. PMID 32258228 DOI: 10.1002/Mdc3.12919 |
0.53 |
|
| 2020 |
Aydin EY, Schneider A, Protic D, Wang JY, Martínez-Cerdeño V, Tassone F, Tang HT, Perlman S, Hagerman RJ. Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease. Clinical Interventions in Aging. 15: 285-292. PMID 32161452 DOI: 10.2147/Cia.S240314 |
0.586 |
|
| 2020 |
Salcedo-Arellano MJ, Hagerman RJ, Martínez-Cerdeño V. Fragile X syndrome: clinical presentation, pathology and treatment. Gaceta Medica De Mexico. 156: 60-66. PMID 32026885 DOI: 10.24875/GMM.19005275 |
0.407 |
|
| 2020 |
Salcedo-Arellano MJ, Dufour B, McLennan Y, Martinez-Cerdeno V, Hagerman R. Fragile X syndrome and associated disorders: Clinical aspects and pathology. Neurobiology of Disease. 136: 104740. PMID 31927143 DOI: 10.1016/J.Nbd.2020.104740 |
0.494 |
|
| 2020 |
Santos E, Emeka-Nwonovo C, Wang JY, Schneider A, Tassone F, Hagerman P, Hagerman R. Developmental aspects of FXAND in a man with the FMR1 premutation. Molecular Genetics & Genomic Medicine. e1050. PMID 31899609 DOI: 10.1002/Mgg3.1050 |
0.643 |
|
| 2020 |
Salcedo-Arellano MJ, Hagerman RJ, Martinez-Cerdeno V. [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment]. Revista De Neurologia. 68: 199-206. PMID 30805918 DOI: 10.33588/rn.6805.2018457 |
0.377 |
|
| 2019 |
Tan MM, Dy JB, Salcedo-Arellano MJ, Tassone F, Hagerman RJ. Fragile X- associated Neuropsychiatric Disorders: A Case Report. Future Neurology. 14. PMID 32089651 DOI: 10.2217/fnl-2018-0040 |
0.424 |
|
| 2019 |
Kim K, Hessl D, Randol JL, Espinal GM, Schneider A, Protic D, Aydin EY, Hagerman RJ, Hagerman PJ. Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions. Plos One. 14: e0226811. PMID 31891607 DOI: 10.1371/Journal.Pone.0226811 |
0.713 |
|
| 2019 |
Potter LA, Scholze DA, Biag HMB, Schneider A, Chen Y, Nguyen DV, Rajaratnam A, Rivera SM, Dwyer PS, Tassone F, Al Olaby RR, Choudhary NS, Salcedo-Arellano MJ, Hagerman RJ. A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder. Frontiers in Psychiatry. 10: 810. PMID 31780970 DOI: 10.3389/Fpsyt.2019.00810 |
0.523 |
|
| 2019 |
Wang JY, Hessl D, Tassone F, Kim K, Hagerman RJ, Rivera SM. Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles. Neurobiology of Aging. PMID 31733943 DOI: 10.1016/J.Neurobiolaging.2019.09.009 |
0.591 |
|
| 2019 |
Biag HMB, Potter LA, Wilkins V, Afzal S, Rosvall A, Salcedo-Arellano MJ, Rajaratnam A, Manzano-Nunez R, Schneider A, Tassone F, Rivera SM, Hagerman RJ. Metformin treatment in young children with fragile X syndrome. Molecular Genetics & Genomic Medicine. e956. PMID 31520524 DOI: 10.1002/Mgg3.956 |
0.55 |
|
| 2019 |
Protic D, Salcedo-Arellano MJ, Dy JB, Potter LA, Hagerman RJ. New Targeted Treatments in Fragile X Syndrome. Current Pediatric Reviews. PMID 31241016 DOI: 10.2174/1573396315666190625110748 |
0.382 |
|
| 2019 |
Protic D, Aydin EY, Tassone F, Tan MM, Hagerman RJ, Schneider A. Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases. Molecular Genetics & Genomic Medicine. e745. PMID 31104364 DOI: 10.1002/Mgg3.745 |
0.584 |
|
| 2019 |
Sachdeva A, Jain P, Gunasekaran V, Mahay SB, Mukherjee S, Hagerman R, Shankar S, Kapoor S, Kedia SN. Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India. Indian Pediatrics. 56: 221-228. PMID 30954995 |
0.335 |
|
| 2019 |
Tartaglia N, Bonn-Miller M, Hagerman R. Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature. Cannabis and Cannabinoid Research. 4: 3-9. PMID 30944868 DOI: 10.1089/can.2018.0053 |
0.335 |
|
| 2019 |
Hagerman R, Tuchman R. Turning the tide on targeted treatments for neurodevelopmental disorders. Neurology. 92: 741-742. PMID 30918096 DOI: 10.1212/Wnl.0000000000007301 |
0.401 |
|
| 2019 |
Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, Zhang L, Leehey MA. Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Movement Disorders Clinical Practice. 6: 120-124. PMID 30838310 DOI: 10.1002/mdc3.12708 |
0.355 |
|
| 2019 |
Hessl D, Harvey D, Sansone S, Crestodina C, Chin J, Joshi R, Hagerman RJ, Berry-Kravis E. Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome. Plos One. 14: e0209984. PMID 30653533 DOI: 10.1371/journal.pone.0209984 |
0.626 |
|
| 2019 |
Sachdeva A, Jain P, Gunasekaran V, Mahay SB, Mukherjee S, Hagerman R, Shankar S, Kapoor S, Kedia SN. Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India. Indian Pediatrics. 56: 221-228. DOI: 10.1007/S13312-019-1504-8 |
0.438 |
|
| 2018 |
El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Fentanyl overdose in a female with the premutation and FXTAS. Journal of Molecular Genetics (Isleworth, London, England). 1. PMID 31032490 DOI: 10.31038/JMG.1000101 |
0.599 |
|
| 2018 |
Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, Weber JD, Abbeduto L, Hessl D, Hagerman RJ, Berry-Kravis E. Best Practices in Fragile X Syndrome Treatment Development. Brain Sciences. 8. PMID 30558274 DOI: 10.3390/Brainsci8120224 |
0.615 |
|
| 2018 |
Martínez Cerdeño V, Hong T, Amina S, Lechpammer M, Ariza J, Tassone F, Noctor SC, Hagerman P, Hagerman R. Microglial cell activation and senescence are characteristic of the pathology FXTAS. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30537011 DOI: 10.1002/Mds.27553 |
0.504 |
|
| 2018 |
Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. Fragile X-Associated Neuropsychiatric Disorders (FXAND). Frontiers in Psychiatry. 9: 564. PMID 30483160 DOI: 10.3389/Fpsyt.2018.00564 |
0.61 |
|
| 2018 |
Ramírez-Cheyne JA, Duque GA, Ayala-Zapata S, Saldarriaga-Gil W, Hagerman P, Hagerman R, Payán-Gómez C. FRAGILE X SYNDROME AND CONNECTIVE TISSUE CONNECTIVE TISSUE DEFICITS IN FRAGILE X SYNDROME. Clinical Genetics. PMID 30414172 DOI: 10.1111/Cge.13469 |
0.345 |
|
| 2018 |
Saldarriaga W, Salcedo-Arellano MJ, Rodriguez-Guerrero T, Ríos M, Fandiño-Losada A, Ramirez-Cheyne J, Lein PJ, Tassone F, Hagerman RJ. Increased Severity of Fragile X Spectrum Disorders in the Agricultural Community of Ricaurte, Colombia. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. PMID 30385191 DOI: 10.1016/J.Ijdevneu.2018.10.002 |
0.411 |
|
| 2018 |
Napoli E, Schneider A, Hagerman R, Song G, Wong S, Tassone F, Giulivi C. Impact of Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins. Frontiers in Genetics. 9: 338. PMID 30210529 DOI: 10.3389/Fgene.2018.00338 |
0.516 |
|
| 2018 |
Napoli E, Schneider A, Wang JY, Trivedi A, Carrillo NR, Tassone F, Rogawski M, Hagerman RJ, Giulivi C. Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study. Molecular Neurobiology. PMID 30187385 DOI: 10.1007/S12035-018-1330-3 |
0.551 |
|
| 2018 |
Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ. Presence of Middle Cerebellar Peduncle Sign in Premutation Carriers Without Tremor and Ataxia. Frontiers in Neurology. 9: 695. PMID 30186228 DOI: 10.3389/fneur.2018.00695 |
0.592 |
|
| 2018 |
Jacquemont S, Pacini L, Jønch AE, Cencelli G, Rozenberg I, He Y, D'Andrea L, Pedini G, Eldeeb M, Willemsen R, Gasparini F, Tassone F, Hagerman R, Gomez-Mancilla B, Bagni C. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Human Molecular Genetics. PMID 30107584 DOI: 10.1093/Hmg/Ddy291 |
0.431 |
|
| 2018 |
Shelton AL, Wang JY, Fourie E, Tassone F, Chen A, Frizzi L, Hagerman RJ, Ferrer E, Hessl D, Rivera SM. Middle Cerebellar Peduncle Width-A Novel MRI Biomarker for FXTAS? Frontiers in Neuroscience. 12: 379. PMID 29988561 DOI: 10.3389/Fnins.2018.00379 |
0.61 |
|
| 2018 |
Hall DA, Hagerman RJ. Fragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future. Frontiers in Genetics. 9: 100. PMID 29951081 DOI: 10.3389/fgene.2018.00100 |
0.385 |
|
| 2018 |
Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General Anesthetic Use in Fragile X Spectrum Disorders. Journal of Neurosurgical Anesthesiology. PMID 29734272 DOI: 10.1097/Ana.0000000000000508 |
0.487 |
|
| 2018 |
Lubala TK, Lumaka A, Kanteng G, Mutesa L, Mukuku O, Wembonyama S, Hagerman R, Luboya ON, Lukusa Tshilobo P. Fragile X checklists: A meta-analysis and development of a simplified universal clinical checklist. Molecular Genetics & Genomic Medicine. PMID 29624914 DOI: 10.1002/mgg3.398 |
0.372 |
|
| 2018 |
Jacquemont S, Pacini L, Jønch AE, Cencelli G, Rozenberg I, He Y, D'Andrea L, Pedini G, Eldeeb M, Willemsen R, Gasparini F, Tassone F, Hagerman R, Gomez-Mancilla B, Bagni C. Protein synthesis levels are increased in a subset of individuals with Fragile X syndrome. Human Molecular Genetics. PMID 29590342 DOI: 10.1093/hmg/ddy099 |
0.321 |
|
| 2018 |
Saldarriaga W, Forero-Forero JV, González-Teshima LY, Fandiño-Losada A, Isaza C, Tovar-Cuevas JR, Silva M, Choudhary NS, Tang HT, Aguilar-Gaxiola S, Hagerman RJ, Tassone F. Genetic cluster of fragile X syndrome in a Colombian district. Journal of Human Genetics. PMID 29379191 DOI: 10.1038/S10038-017-0407-6 |
0.309 |
|
| 2018 |
Dy ABC, Tassone F, Eldeeb M, Salcedo‐Arellano MJ, Tartaglia N, Hagerman R. Metformin as targeted treatment in fragile X syndrome. Clinical Genetics. 93: 216-222. PMID 28436599 DOI: 10.1111/Cge.13039 |
0.354 |
|
| 2017 |
Burris JL, Barry-Anwar RA, Sims RN, Hagerman RJ, Tassone F, Rivera SM. Children With Fragile X Syndrome Display Threat-Specific Biases Toward Emotion. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 487-492. PMID 29348038 DOI: 10.1016/j.bpsc.2017.06.003 |
0.407 |
|
| 2017 |
Rajaratnam A, Shergill J, Salcedo-Arellano M, Saldarriaga W, Duan X, Hagerman R. Fragile X syndrome and fragile X-associated disorders. F1000research. 6: 2112. PMID 29259781 DOI: 10.12688/f1000research.11885.1 |
0.435 |
|
| 2017 |
Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, ... ... Hagerman R, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews. Drug Discovery. PMID 29217836 DOI: 10.1038/nrd.2017.221 |
0.628 |
|
| 2017 |
Jiraanont P, Sweha SR, AlOlaby RR, Silva M, Tang HT, Durbin-Johnson B, Schneider A, Espinal GM, Hagerman PJ, Rivera SM, Hessl D, Hagerman RJ, Chutabhakdikul N, Tassone F. Clinical and molecular correlates in fragile X premutation females. Eneurologicalsci. 7: 49-56. PMID 28971146 DOI: 10.1016/J.Ensci.2017.04.003 |
0.704 |
|
| 2017 |
Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ. Fragile X syndrome. Nature Reviews. Disease Primers. 3: 17065. PMID 28960184 DOI: 10.1038/nrdp.2017.65 |
0.385 |
|
| 2017 |
Jiraanont P, Kumar M, Tang HT, Espinal G, Hagerman PJ, Hagerman RJ, Chutabhakdikul N, Tassone F. Size and methylation mosaicism in males with Fragile X syndrome. Expert Review of Molecular Diagnostics. PMID 28929824 DOI: 10.1080/14737159.2017.1377612 |
0.386 |
|
| 2017 |
Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, et al. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28816242 DOI: 10.1038/Npp.2017.177 |
0.612 |
|
| 2017 |
Ligsay A, Van Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, Hessl D, Schneider A, Angkustsiri K, Tassone F, Ceulemans B, Kooy RF, Hagerman RJ. A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders. 9: 26. PMID 28764646 DOI: 10.1186/S11689-017-9207-8 |
0.707 |
|
| 2017 |
Niu M, Han Y, Dy ABC, Du J, Jin H, Qin J, Zhang J, Li Q, Hagerman RJ. Fragile X Syndrome: Prevalence, Treatment, and Prevention in China. Frontiers in Neurology. 8: 254. PMID 28634468 DOI: 10.3389/fneur.2017.00254 |
0.328 |
|
| 2017 |
Niu M, Han Y, Dy ABC, Du J, Jin H, Qin J, Zhang J, Li Q, Hagerman RJ. Autism Symptoms in Fragile X Syndrome. Journal of Child Neurology. 883073817712875. PMID 28617074 DOI: 10.1177/0883073817712875 |
0.337 |
|
| 2017 |
Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E. Fragile X targeted pharmacotherapy: lessons learned and future directions. Journal of Neurodevelopmental Disorders. 9: 7. PMID 28616096 DOI: 10.1186/S11689-017-9186-9 |
0.566 |
|
| 2017 |
Berry-Kravis E, Hagerman R, Visootsak J, Budimirovic D, Kaufmann WE, Cherubini M, Zarevics P, Walton-Bowen K, Wang P, Bear MF, Carpenter RL. Arbaclofen in fragile X syndrome: results of phase 3 trials. Journal of Neurodevelopmental Disorders. 9: 3. PMID 28616094 DOI: 10.1186/S11689-016-9181-6 |
0.436 |
|
| 2017 |
Martínez-Cerdeño V, Lechpammer M, Noctor S, Ariza J, Hagerman P, Hagerman R. FMR1 premutation with Prader-Willi phenotype and fragile X-associated tremor/ataxia syndrome. Clinical Case Reports. 5: 625-629. PMID 28469864 DOI: 10.1002/Ccr3.834 |
0.484 |
|
| 2017 |
Wang JY, Hessl D, Hagerman RJ, Simon TJ, Tassone F, Ferrer E, Rivera SM. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation. Neurobiology of Aging. 55: 11-19. PMID 28391068 DOI: 10.1016/J.Neurobiolaging.2017.03.018 |
0.62 |
|
| 2017 |
AlOlaby RR, Sweha SR, Silva M, Durbin-Johnson B, Yrigollen CM, Pretto D, Hagerman RJ, Tassone F. Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome. Brain & Development. PMID 28242040 DOI: 10.1016/j.braindev.2017.01.012 |
0.316 |
|
| 2017 |
Boland MJ, Nazor KL, Tran HT, Szücs A, Lynch CL, Paredes R, Tassone F, Sanna PP, Hagerman RJ, Loring JF. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome. Brain : a Journal of Neurology. PMID 28137726 DOI: 10.1093/Brain/Aww357 |
0.392 |
|
| 2017 |
Saldarriaga W, Ruiz FA, Tassone F, Hagerman R. Down Syndrome and Fragile X Syndrome in a Colombian Woman: Case Report. Journal of Applied Research in Intellectual Disabilities : Jarid. 30: 970-974. PMID 27456465 DOI: 10.1111/jar.12272 |
0.339 |
|
| 2016 |
Yrigollen CM, Pacini L, Nobile V, Lozano R, Hagerman RJ, Bagni C, Tassone F. Clinical and Molecular Assessment in a Female with Fragile X Syndrome and Tuberous Sclerosis. Journal of Genetic Disorders & Genetic Reports. 5. PMID 28232951 DOI: 10.4172/2327-5790.1000139 |
0.371 |
|
| 2016 |
Muzar Z, Lozano R, Kolevzon A, Hagerman RJ. The neurobiology of the Prader-Willi phenotype of fragile X syndrome. Intractable & Rare Diseases Research. 5: 255-261. PMID 27904820 DOI: 10.5582/irdr.2016.01082 |
0.403 |
|
| 2016 |
Ligsay A, Hagerman RJ. Review of targeted treatments in fragile X syndrome. Intractable & Rare Diseases Research. 5: 158-67. PMID 27672538 DOI: 10.5582/irdr.2016.01045 |
0.386 |
|
| 2016 |
Lozano R, Azarang A, Wilaisakditipakorn T, Hagerman RJ. Fragile X syndrome: A review of clinical management. Intractable & Rare Diseases Research. 5: 145-57. PMID 27672537 DOI: 10.5582/irdr.2016.01048 |
0.393 |
|
| 2016 |
Gossett A, Sansone S, Schneider A, Johnston C, Hagerman R, Tassone F, Rivera SM, Seritan AL, Hessl D. Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 27615674 DOI: 10.1002/Ajmg.B.32496 |
0.724 |
|
| 2016 |
Giulivi C, Napoli E, Tassone F, Halmai J, Hagerman R. Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers. Frontiers in Molecular Neuroscience. 9: 71. PMID 27570505 DOI: 10.3389/fnmol.2016.00071 |
0.313 |
|
| 2016 |
Greiss Hess L, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul KN, Schneider A, Lemons Chitwood K, Eldeeb MA, Polussa J, Hessl D, Rivera S, Hagerman RJ. A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome. Journal of Developmental and Behavioral Pediatrics : Jdbp. PMID 27560971 DOI: 10.1097/Dbp.0000000000000334 |
0.707 |
|
| 2016 |
Schneider A, Johnston C, Tassone F, Sansone S, Hagerman RJ, Ferrer E, Rivera SM, Hessl D. Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. The Clinical Neuropsychologist. 1-15. PMID 27355445 DOI: 10.1080/13854046.2016.1189536 |
0.718 |
|
| 2016 |
Grigsby J, Brega AG, Bennett RE, Bourgeois JA, Seritan AL, Goodrich GK, Hagerman RJ. Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning. The Clinical Neuropsychologist. 1-16. PMID 27355103 DOI: 10.1080/13854046.2016.1185100 |
0.453 |
|
| 2016 |
Hagerman RJ, Hagerman P. Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. Nature Reviews. Neurology. 12: 403-12. PMID 27340021 DOI: 10.1038/Nrneurol.2016.82 |
0.432 |
|
| 2016 |
Napoli E, Song G, Schneider A, Hagerman R, Eldeeb MA, Azarang A, Tassone F, Giulivi C. Warburg effect linked to cognitive-executive deficits in FMR1 premutation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27335370 DOI: 10.1096/Fj.201600315R |
0.583 |
|
| 2016 |
Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. Aging in Fragile X Premutation Carriers. Cerebellum (London, England). PMID 27334385 DOI: 10.1007/S12311-016-0805-X |
0.673 |
|
| 2016 |
Hall DA, Robertson E, Shelton AL, Losh MC, Mila M, Moreno EG, Gomez-Anson B, Martínez-Cerdeño V, Grigsby J, Lozano R, Hagerman R, Maria LS, Berry-Kravis E, O'Keefe JA. Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers. Cerebellum (London, England). PMID 27287737 DOI: 10.1007/S12311-016-0799-4 |
0.423 |
|
| 2016 |
Wang JY, Ngo MM, Hessl D, Hagerman RJ, Rivera SM. Robust Machine Learning-Based Correction on Automatic Segmentation of the Cerebellum and Brainstem. Plos One. 11: e0156123. PMID 27213683 DOI: 10.1371/journal.pone.0156123 |
0.501 |
|
| 2016 |
Hagerman R. Psychopathology Increases With Age in Fragile X Carrier Mothers. Biological Psychiatry. 79: 790-791. PMID 27130851 DOI: 10.1016/J.Biopsych.2016.03.1052 |
0.384 |
|
| 2016 |
Napoli E, Song G, Wong S, Hagerman R, Giulivi C. Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum (London, England). PMID 27089882 DOI: 10.1007/s12311-016-0779-8 |
0.378 |
|
| 2016 |
Saldarriaga W, Lein P, González Teshima LY, Isaza C, Rosa L, Polyak A, Hagerman R, Girirajan S, Silva M, Tassone F. PHENOBARBITAL USE AND NEUROLOGICAL PROBLEMS IN FMR1 PREMUTATION CARRIERS. Neurotoxicology. PMID 26802682 DOI: 10.1016/J.Neuro.2016.01.008 |
0.318 |
|
| 2016 |
Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, Brinkman M, Rerat K, Koumaras B, Zhu L, Barth GM, Jaecklin T, Apostol G, von Raison F. Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Science Translational Medicine. 8: 321ra5. PMID 26764156 DOI: 10.1126/scitranslmed.aab4109 |
0.321 |
|
| 2016 |
Oakes A, Thurman AJ, McDuffie A, Bullard LM, Hagerman RJ, Abbeduto L. Characterising repetitive behaviours in young boys with fragile X syndrome. Journal of Intellectual Disability Research : Jidr. 60: 54-67. PMID 26449367 DOI: 10.1111/Jir.12234 |
0.388 |
|
| 2015 |
Famula J, Basuta K, Gane LW, Hagerman RJ, Tassone F. Identification of a male with fragile X syndrome through newborn screening. Intractable & Rare Diseases Research. 4: 198-202. PMID 26668780 DOI: 10.5582/irdr.2015.01031 |
0.346 |
|
| 2015 |
Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Translational Medicine. 4: 1369. PMID 26508786 DOI: 10.5966/sctm.2014-0073erratum |
0.533 |
|
| 2015 |
Martínez-Cerdeño V, Lechpammer M, Lott A, Schneider A, Hagerman R. Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s. Jama Neurology. 72: 1070-3. PMID 26368352 DOI: 10.1001/Jamaneurol.2015.1138 |
0.658 |
|
| 2015 |
Lozano R, Martinez-Cerdeno V, Hagerman RJ. Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder. Current Pharmaceutical Design. 21: 4972-9. PMID 26365141 |
0.325 |
|
| 2015 |
Winarni TI, Schneider A, Ghaziuddin N, Seritan A, Hagerman RJ. Psychosis and catatonia in fragile X: Case report and literature review. Intractable & Rare Diseases Research. 4: 139-46. PMID 26361565 DOI: 10.5582/Irdr.2015.01028 |
0.576 |
|
| 2015 |
Cordeiro L, Abucayan F, Hagerman R, Tassone F, Hessl D. Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands. Intractable & Rare Diseases Research. 4: 123-30. PMID 26361563 DOI: 10.5582/irdr.2015.01029 |
0.629 |
|
| 2015 |
Godler DE, Inaba Y, Schwartz CE, Bui QM, Shi EZ, Li X, Herlihy AS, Skinner C, Hagerman RJ, Francis D, Amor DJ, Metcalfe SA, Hopper JL, Slater HR. Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis. Expert Reviews in Molecular Medicine. 17: e13. PMID 26132880 DOI: 10.1017/erm.2015.11 |
0.307 |
|
| 2015 |
Basuta K, Schneider A, Gane L, Polussa J, Woodruff B, Pretto D, Hagerman R, Tassone F. High functioning male with fragile X syndrome and fragile x-associated tremor/ataxia syndrome. American Journal of Medical Genetics. Part A. PMID 25920745 DOI: 10.1002/Ajmg.A.37125 |
0.653 |
|
| 2015 |
Thurman AJ, McDuffie A, Kover ST, Hagerman RJ, Abbeduto L. Autism Symptomatology in Boys with Fragile X Syndrome: A Cross Sectional Developmental Trajectories Comparison with Nonsyndromic Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 45: 2816-32. PMID 25904201 DOI: 10.1007/S10803-015-2443-4 |
0.357 |
|
| 2015 |
Muzar Z, Lozano R, Schneider A, Adams PE, Faradz SM, Tassone F, Hagerman RJ. Methadone use in a male with the FMRI premutation and FXTAS. American Journal of Medical Genetics. Part A. 167: 1354-9. PMID 25900641 DOI: 10.1002/Ajmg.A.37030 |
0.542 |
|
| 2015 |
Benjamin DP, McDuffie AS, Thurman AJ, Kover ST, Mastergeorge AM, Hagerman RJ, Abbeduto L. Effect of speaker gaze on word learning in fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder. Journal of Speech, Language, and Hearing Research : Jslhr. 58: 383-95. PMID 25629603 DOI: 10.1044/2015_Jslhr-L-14-0136 |
0.357 |
|
| 2015 |
Hagerman PJ, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome. Annals of the New York Academy of Sciences. 1338: 58-70. PMID 25622649 DOI: 10.1111/Nyas.12693 |
0.453 |
|
| 2015 |
Hagerman RJ, Polussa J. Treatment of the psychiatric problems associated with fragile X syndrome. Current Opinion in Psychiatry. 28: 107-12. PMID 25602250 DOI: 10.1097/YCO.0000000000000131 |
0.377 |
|
| 2015 |
Jalnapurkar I, Rafika N, Tassone F, Hagerman R. Immune mediated disorders in women with a fragile X expansion and FXTAS. American Journal of Medical Genetics. Part A. 167: 190-7. PMID 25399540 DOI: 10.1002/ajmg.a.36748 |
0.35 |
|
| 2015 |
Ram S, Devapriya IA, Fenton G, Mcvay L, Nguyen DV, Tassone F, Maselli RA, Hagerman RJ. Axonal neuropathy in female carriers of the fragile X premutation with fragile x-associated tremor ataxia syndrome. Muscle & Nerve. 52: 234-9. PMID 25388402 DOI: 10.1002/Mus.24515 |
0.382 |
|
| 2015 |
Thurman AJ, McDuffie A, Kover ST, Hagerman R, Channell MM, Mastergeorge A, Abbeduto L. Use of emotional cues for lexical learning: a comparison of autism spectrum disorder and fragile X syndrome. Journal of Autism and Developmental Disorders. 45: 1042-61. PMID 25318904 DOI: 10.1007/S10803-014-2260-1 |
0.309 |
|
| 2015 |
McDuffie A, Thurman AJ, Hagerman RJ, Abbeduto L. Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores. Journal of Autism and Developmental Disorders. 45: 1925-37. PMID 24414079 DOI: 10.1007/S10803-013-2013-6 |
0.331 |
|
| 2014 |
Au J, Berkowitz-Sutherland L, Schneider A, Schweitzer JB, Hessl D, Hagerman R. A feasibility trial of Cogmed working memory training in fragile X syndrome. Journal of Pediatric Genetics. 3: 147-56. PMID 27625871 DOI: 10.3233/Pge-14098 |
0.701 |
|
| 2014 |
Saldarriaga W, Tassone F, González-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R. Fragile X syndrome. Colombia Medica (Cali, Colombia). 45: 190-8. PMID 25767309 |
0.405 |
|
| 2014 |
Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA. Emerging topics in FXTAS. Journal of Neurodevelopmental Disorders. 6: 31. PMID 25642984 DOI: 10.1186/1866-1955-6-31 |
0.329 |
|
| 2014 |
Díez-Juan M, Schneider A, Phillips T, Lozano R, Tassone F, Solomon M, Hagerman RJ. Parent-delivered touchscreen intervention for children with fragile X syndrome. Intractable & Rare Diseases Research. 3: 166-77. PMID 25606367 DOI: 10.5582/Irdr.2014.01026 |
0.535 |
|
| 2014 |
Muzar Z, Adams PE, Schneider A, Hagerman RJ, Lozano R. Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases. Intractable & Rare Diseases Research. 3: 162-5. PMID 25606366 DOI: 10.5582/Irdr.2014.01023 |
0.552 |
|
| 2014 |
Chechi T, Siyahian S, Thairu L, Hagerman R, Lozano R. Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders. Intractable & Rare Diseases Research. 3: 147-52. PMID 25606364 DOI: 10.5582/Irdr.2014.01025 |
0.384 |
|
| 2014 |
Lozano R, Rosero CA, Hagerman RJ. Fragile X spectrum disorders. Intractable & Rare Diseases Research. 3: 134-46. PMID 25606363 DOI: 10.5582/irdr.2014.01022 |
0.396 |
|
| 2014 |
Hanson AC, Hagerman RJ. Serotonin dysregulation in Fragile X Syndrome: implications for treatment. Intractable & Rare Diseases Research. 3: 110-7. PMID 25606361 DOI: 10.5582/irdr.2014.01027 |
0.354 |
|
| 2014 |
Hagerman R, Lozano R, Schneider A. Translational research guided by animal studies in Fragile X Disorders. Intractable & Rare Diseases Research. 3: 100. PMID 25606359 DOI: 10.5582/Irdr.2014.01033 |
0.642 |
|
| 2014 |
Polussa J, Schneider A, Hagerman R. Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disorders & Therapy. 3. PMID 25436181 DOI: 10.4172/2168-975X.1000119 |
0.638 |
|
| 2014 |
Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Translational Medicine. 3: 1275-86. PMID 25273538 DOI: 10.5966/Sctm.2014-0073 |
0.575 |
|
| 2014 |
Lozano R, Hare EB, Hagerman RJ. Modulation of the GABAergic pathway for the treatment of fragile X syndrome. Neuropsychiatric Disease and Treatment. 10: 1769-79. PMID 25258535 DOI: 10.2147/NDT.S42919 |
0.319 |
|
| 2014 |
Lozano R, Hagerman RJ, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. Genomic studies in fragile X premutation carriers. Journal of Neurodevelopmental Disorders. 6: 27. PMID 25170347 DOI: 10.1186/1866-1955-6-27 |
0.376 |
|
| 2014 |
Tassone F, Hagerman PJ, Hagerman RJ. Fragile x premutation. Journal of Neurodevelopmental Disorders. 6: 22. PMID 25170346 DOI: 10.1186/1866-1955-6-22 |
0.401 |
|
| 2014 |
Yang JC, Chi L, Teichholtz S, Schneider A, Nanakul R, Nowacki R, Seritan A, Reed B, DeCarli C, Iragui VJ, Kutas M, Hagerman PJ, Hagerman RJ, Olichney JM. ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI. Neuropsychologia. 63: 34-42. PMID 25111034 DOI: 10.1016/J.Neuropsychologia.2014.08.001 |
0.596 |
|
| 2014 |
Wheeler AC, Bailey DB, Berry-Kravis E, Greenberg J, Losh M, Mailick M, Milà M, Olichney JM, Rodriguez-Revenga L, Sherman S, Smith L, Summers S, Yang JC, Hagerman R. Associated features in females with an FMR1 premutation. Journal of Neurodevelopmental Disorders. 6: 30. PMID 25097672 DOI: 10.1186/1866-1955-6-30 |
0.376 |
|
| 2014 |
Besterman AD, Wilke SA, Mulligan TE, Allison SC, Hagerman R, Seritan AL, Bourgeois JA. Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers. Future Neurology. 9: 227-239. PMID 25013385 DOI: 10.2217/fnl.14.11 |
0.412 |
|
| 2014 |
Lozano R, Summers S, Lozano C, Mu Y, Hessl D, Nguyen D, Tassone F, Hagerman R. Association between macroorchidism and intelligence in FMR1 premutation carriers. American Journal of Medical Genetics. Part A. 164: 2206-11. PMID 24903624 DOI: 10.1002/Ajmg.A.36624 |
0.577 |
|
| 2014 |
Yang JC, Niu YQ, Simon C, Seritan AL, Chen L, Schneider A, Moghaddam ST, Hagerman PJ, Hagerman RJ, Olichney JM. Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2760-8. PMID 24871547 DOI: 10.1038/Npp.2014.122 |
0.522 |
|
| 2014 |
Ballinger EC, Cordeiro L, Chavez AD, Hagerman RJ, Hessl D. Emotion potentiated startle in fragile X syndrome. Journal of Autism and Developmental Disorders. 44: 2536-46. PMID 24816942 DOI: 10.1007/s10803-014-2125-7 |
0.583 |
|
| 2014 |
Hagerman RJ, Des-Portes V, Gasparini F, Jacquemont S, Gomez-Mancilla B. Translating molecular advances in fragile X syndrome into therapy: a review. The Journal of Clinical Psychiatry. 75: e294-307. PMID 24813413 DOI: 10.4088/JCP.13r08714 |
0.401 |
|
| 2014 |
Inaba Y, Schwartz CE, Bui QM, Li X, Skinner C, Field M, Wotton T, Hagerman RJ, Francis D, Amor DJ, Hopper JL, Loesch DZ, Bretherton L, Slater HR, Godler DE. Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots. Clinical Chemistry. 60: 963-73. PMID 24778142 DOI: 10.1373/clinchem.2013.217331 |
0.335 |
|
| 2014 |
Thurman AJ, McDuffie A, Hagerman R, Abbeduto L. Psychiatric symptoms in boys with fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder. Research in Developmental Disabilities. 35: 1072-86. PMID 24629733 DOI: 10.1016/J.Ridd.2014.01.032 |
0.367 |
|
| 2014 |
Pretto DI, Mendoza-Morales G, Lo J, Cao R, Hadd A, Latham GJ, Durbin-Johnson B, Hagerman R, Tassone F. CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. Journal of Medical Genetics. 51: 309-18. PMID 24591415 DOI: 10.1136/jmedgenet-2013-102021 |
0.303 |
|
| 2014 |
Niu YQ, Yang JC, Hall DA, Leehey MA, Tassone F, Olichney JM, Hagerman RJ, Zhang L. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Parkinsonism & Related Disorders. 20: 456-9. PMID 24491663 DOI: 10.1016/j.parkreldis.2014.01.006 |
0.373 |
|
| 2014 |
Seritan AL, Nguyen DV, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell JB, Cook KR, Leehey MA, Grigsby J, Olichney JM, Adams PE, Legg W, Zhang L, Hagerman PJ, ... Hagerman RJ, et al. Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 75: 264-71. PMID 24345444 DOI: 10.4088/Jcp.13M08546 |
0.539 |
|
| 2014 |
Pretto DI, Kumar M, Cao Z, Cunningham CL, Durbin-Johnson B, Qi L, Berman R, Noctor SC, Hagerman RJ, Pessah IN, Tassone F. Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome. Neurobiology of Aging. 35: 1189-97. PMID 24332449 DOI: 10.1016/J.Neurobiolaging.2013.11.009 |
0.344 |
|
| 2014 |
Yang JC, Simon C, Schneider A, Seritan AL, Hamilton L, Hagerman PJ, Hagerman RJ, Olichney JM. Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome. Genes, Brain, and Behavior. 13: 152-62. PMID 24299169 DOI: 10.1111/Gbb.12114 |
0.539 |
|
| 2014 |
Gomez-Mancilla B, Berry-Kravis E, Hagerman R, von Raison F, Apostol G, Ufer M, Gasparini F, Jacquemont S. Development of mavoglurant and its potential for the treatment of fragile X syndrome. Expert Opinion On Investigational Drugs. 23: 125-34. PMID 24251408 DOI: 10.1517/13543784.2014.857400 |
0.355 |
|
| 2014 |
Jacquemont S, Berry-Kravis E, Hagerman R, von Raison F, Gasparini F, Apostol G, Ufer M, Des Portes V, Gomez-Mancilla B. The challenges of clinical trials in fragile X syndrome. Psychopharmacology. 231: 1237-50. PMID 24173622 DOI: 10.1007/s00213-013-3289-0 |
0.338 |
|
| 2014 |
María LS, Pugin A, Alliende MA, Aliaga S, Curotto B, Aravena T, Tang H-, Mendoza-Morales G, Hagerman R, Tassone F. FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile. Clinical Genetics. 86: 378-382. PMID 24028275 DOI: 10.1111/Cge.12278 |
0.5 |
|
| 2014 |
Zhang L, Sukharev D, Schneider A, Olichney JM, Seritan A, Hagerman RJ. Case report: Dystonia in a fragile X carrier. Movement Disorders : Official Journal of the Movement Disorder Society. 29: E4-5. PMID 21469199 DOI: 10.1002/Mds.23600 |
0.63 |
|
| 2014 |
Hare EB, Hagerman RJ, Lozano R. Targeted treatments in fragile X syndrome Expert Opinion On Orphan Drugs. 2: 531-543. DOI: 10.1517/21678707.2014.903795 |
0.326 |
|
| 2014 |
Lozano R, Hare EB, Hagerman RJ. Fragile X-Associated Disorders Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 183-195. DOI: 10.1016/B978-0-12-410529-4.00017-6 |
0.453 |
|
| 2014 |
Summers SM, Hagerman R. Fragile X-Associated Disorders Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. 120-129. DOI: 10.1016/B978-0-12-398270-4.00008-2 |
0.44 |
|
| 2013 |
Seritan AL, Bourgeois JA, Schneider A, Mu Y, Hagerman RJ, Nguyen DV. Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers. Current Psychiatry Reviews. 9: 65-71. PMID 25844075 DOI: 10.2174/157340013805289662 |
0.514 |
|
| 2013 |
Wadell PM, Hagerman RJ, Hessl DR. FRAGILE X SYNDROME: PSYCHIATRIC MANIFESTATIONS, ASSESSMENT AND EMERGING THERAPIES. Current Psychiatry Reviews. 9: 53-58. PMID 25632275 DOI: 10.2174/157340013805289644 |
0.674 |
|
| 2013 |
Seritan AL, Ortigas M, Seritan S, Bourgeois JA, Hagerman RJ. PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. Current Psychiatry Reviews. 9: 59-64. PMID 25620899 DOI: 10.2174/157340013805289699 |
0.345 |
|
| 2013 |
Schneider A, Leigh MJ, Adams P, Nanakul R, Chechi T, Olichney J, Hagerman R, Hessl D. Electrocortical changes associated with minocycline treatment in fragile X syndrome. Journal of Psychopharmacology (Oxford, England). 27: 956-63. PMID 23981511 DOI: 10.1177/0269881113494105 |
0.68 |
|
| 2013 |
Schneider A, Ligsay A, Hagerman RJ. Fragile X syndrome: an aging perspective. Developmental Disabilities Research Reviews. 18: 68-74. PMID 23949830 DOI: 10.1002/Ddrr.1129 |
0.606 |
|
| 2013 |
Schneider A, Seritan A, Tassone F, Rivera SM, Hagerman R, Hessl D. Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders. The Primary Care Companion For Cns Disorders. 15. PMID 23930232 DOI: 10.4088/Pcc.12L01492 |
0.739 |
|
| 2013 |
Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. The Lancet. Neurology. 12: 786-98. PMID 23867198 DOI: 10.1016/S1474-4422(13)70125-X |
0.436 |
|
| 2013 |
Basuta K, Lozano R, Schneider A, Yrigollen CM, Hessl D, Hagerman RJ, Tassone F. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clinical Genetics. 85: 458-63. PMID 23786467 DOI: 10.1111/Cge.12218 |
0.692 |
|
| 2013 |
Wang JY, Hessl D, Schneider A, Tassone F, Hagerman RJ, Rivera SM. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. Jama Neurology. 70: 1022-9. PMID 23753897 DOI: 10.1001/Jamaneurol.2013.2934 |
0.691 |
|
| 2013 |
Pretto DI, Hunsaker MR, Cunningham CL, Greco CM, Hagerman RJ, Noctor SC, Hall DA, Hagerman PJ, Tassone F. Intranuclear inclusions in a fragile X mosaic male. Translational Neurodegeneration. 2: 10. PMID 23692864 DOI: 10.1186/2047-9158-2-10 |
0.41 |
|
| 2013 |
Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. Phenotypes of hypofrontality in older female fragile X premutation carriers. Annals of Neurology. 74: 275-83. PMID 23686745 DOI: 10.1002/Ana.23933 |
0.577 |
|
| 2013 |
Wang JY, Hagerman RJ, Rivera SM. A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1278-84. PMID 23649693 DOI: 10.1002/mds.25473 |
0.368 |
|
| 2013 |
Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Schneider A, Chechi T, Polussa J, Doucet P, Tassone F, Rivera SM, Hessl D, Hagerman RJ. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. Journal of Developmental and Behavioral Pediatrics : Jdbp. 34: 147-55. PMID 23572165 DOI: 10.1097/Dbp.0B013E318287Cd17 |
0.693 |
|
| 2013 |
Loesch D, Hagerman R. Unstable mutations in the FMR1 gene and the phenotypes. Advances in Experimental Medicine and Biology. 769: 78-114. PMID 23560306 DOI: 10.1007/978-1-4614-5434-2_6 |
0.521 |
|
| 2013 |
Wang JY, Hessl D, Iwahashi C, Cheung K, Schneider A, Hagerman RJ, Hagerman PJ, Rivera SM. Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles. Neuroimage. 65: 288-98. PMID 23063447 DOI: 10.1016/J.Neuroimage.2012.09.075 |
0.645 |
|
| 2013 |
Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cerebral Cortex (New York, N.Y. : 1991). 23: 2657-66. PMID 22918986 DOI: 10.1093/Cercor/Bhs251 |
0.536 |
|
| 2012 |
Bagni C, Tassone F, Neri G, Hagerman R. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. The Journal of Clinical Investigation. 122: 4314-22. PMID 23202739 DOI: 10.1172/Jci63141 |
0.375 |
|
| 2012 |
Abrams L, Cronister A, Brown WT, Tassone F, Sherman SL, Finucane B, McConkie-Rosell A, Hagerman R, Kaufmann WE, Picker J, Coffey S, Skinner D, Johnson V, Miller R, Berry-Kravis E. Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics. 130: 1126-35. PMID 23129072 DOI: 10.1542/Peds.2012-0693 |
0.495 |
|
| 2012 |
Winarni TI, Schneider A, Borodyanskara M, Hagerman RJ. Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome. Case Reports in Genetics. 2012: 280813. PMID 23074686 DOI: 10.1155/2012/280813 |
0.56 |
|
| 2012 |
Castrén E, Elgersma Y, Maffei L, Hagerman R. Treatment of neurodevelopmental disorders in adulthood. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 14074-9. PMID 23055475 DOI: 10.1523/Jneurosci.3287-12.2012 |
0.34 |
|
| 2012 |
Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzalez-Heydrich J, Wang PP, Carpenter RL, Bear MF, Hagerman RJ. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Science Translational Medicine. 4: 152ra127. PMID 22993294 DOI: 10.1126/Scitranslmed.3004214 |
0.652 |
|
| 2012 |
Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, Nguyen DV, Loesch D, Hagerman RJ. Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). American Journal of Medical Genetics. Part A. 158: 1304-9. PMID 22528549 DOI: 10.1002/Ajmg.A.35323 |
0.613 |
|
| 2012 |
Wang JY, Hessl DH, Hagerman RJ, Tassone F, Rivera SM. Age-dependent structural connectivity effects in fragile x premutation. Archives of Neurology. 69: 482-9. PMID 22491193 DOI: 10.1001/archneurol.2011.2023 |
0.625 |
|
| 2012 |
Sorensen PL, Basuta K, Mendoza-Morales G, Gane LW, Schneider A, Hagerman R, Tassone F. A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male. American Journal of Medical Genetics. Part A. 158: 1221-4. PMID 22488807 DOI: 10.1002/Ajmg.A.35293 |
0.486 |
|
| 2012 |
Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes, Brain, and Behavior. 11: 577-85. PMID 22463693 DOI: 10.1111/J.1601-183X.2012.00779.X |
0.326 |
|
| 2012 |
Godler DE, Slater HR, Bui QM, Storey E, Ono MY, Gehling F, Inaba Y, Francis D, Hopper JL, Kinsella G, Amor DJ, Hagerman RJ, Loesch DZ. Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. Clinical Chemistry. 58: 590-8. PMID 22235103 DOI: 10.1373/clinchem.2011.177626 |
0.313 |
|
| 2012 |
Tassone F, Hagerman R. The fragile X-associated tremor ataxia syndrome. Results and Problems in Cell Differentiation. 54: 337-57. PMID 22009361 DOI: 10.1007/978-3-642-21649-7_18 |
0.383 |
|
| 2012 |
Hagerman R, Lauterborn J, Au J, Berry-Kravis E. Fragile X syndrome and targeted treatment trials Results and Problems in Cell Differentiation. 54: 297-335. PMID 22009360 DOI: 10.1007/978-3-642-21649-7_17 |
0.362 |
|
| 2012 |
Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, Mu Y, Tassone F, Nguyen DV, Hagerman RJ. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Human Genetics. 131: 581-9. PMID 22001913 DOI: 10.1007/S00439-011-1106-6 |
0.665 |
|
| 2012 |
Hagerman RJ. The fragile X-associated disorders: time to order fragile X DNA testing. Biological Psychiatry. 70: 802-3. PMID 21986091 DOI: 10.1016/j.biopsych.2011.09.009 |
0.318 |
|
| 2012 |
Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman RJ, Hessl D. Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiology of Aging. 33: 1045-53. PMID 20961665 DOI: 10.1016/J.Neurobiolaging.2010.09.002 |
0.74 |
|
| 2012 |
Zhang L, Liu Y, Tassone F, Leehey M, Hagerman R. Neurology Education on FXTAS across the World: From Training Foreign Specialists in the US to Opening a Specialty Clinic in China (P06.031) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.031 |
0.383 |
|
| 2012 |
Vaughan C, Ouyang B, Goetz C, Berry-Kravis E, Hagerman R, Leehey M, Hall D. Dystonia in FMR1 Premutation Carriers (P01.222) Neurology. 78: P01.222-P01.222. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.222 |
0.443 |
|
| 2011 |
Sumekar TA, Ashrani AA, Winarni TI, Hagerman RJ. Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome. Case Reports in Genetics. 2011: 143132. PMID 23074671 DOI: 10.1155/2011/143132 |
0.379 |
|
| 2011 |
McLennan Y, Polussa J, Tassone F, Hagerman R. Fragile x syndrome. Current Genomics. 12: 216-24. PMID 22043169 DOI: 10.2174/138920211795677886 |
0.396 |
|
| 2011 |
Leehey MA, Legg W, Tassone F, Hagerman R. Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology (Oxford, England). 50: 2233-6. PMID 21926154 DOI: 10.1093/rheumatology/ker273 |
0.34 |
|
| 2011 |
Selmeczy D, Koldewyn K, Wang JM, Lee A, Harvey D, Hessl DR, Tassone F, Adams P, Hagerman RJ, Hagerman PJ, Rivera SM. Investigation of amygdala volume in men with the fragile X premutation. Brain Imaging and Behavior. 5: 285-94. PMID 21786216 DOI: 10.1007/S11682-011-9132-5 |
0.62 |
|
| 2011 |
Hagerman R, Au J, Hagerman P. FMR1 premutation and full mutation molecular mechanisms related to autism. Journal of Neurodevelopmental Disorders. 3: 211-24. PMID 21617890 DOI: 10.1007/S11689-011-9084-5 |
0.373 |
|
| 2011 |
Hunsaker MR, Greco CM, Tassone F, Berman RF, Willemsen R, Hagerman RJ, Hagerman PJ. Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders. Journal of Neuropathology and Experimental Neurology. 70: 462-9. PMID 21572337 DOI: 10.1097/Nen.0B013E31821D3194 |
0.353 |
|
| 2011 |
Hashimoto R, Srivastava S, Tassone F, Hagerman RJ, Rivera SM. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1329-36. PMID 21484870 DOI: 10.1002/mds.23646 |
0.321 |
|
| 2011 |
Cordeiro L, Ballinger E, Hagerman R, Hessl D. Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization. Journal of Neurodevelopmental Disorders. 3: 57-67. PMID 21475730 DOI: 10.1007/S11689-010-9067-Y |
0.647 |
|
| 2011 |
Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain : a Journal of Neurology. 134: 863-78. PMID 21354978 DOI: 10.1093/brain/awq368 |
0.346 |
|
| 2011 |
Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, Tassone F. Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. American Journal of Medical Genetics. Part A. 155: 519-25. PMID 21344625 DOI: 10.1002/ajmg.a.33446 |
0.442 |
|
| 2011 |
Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F, Delany M, Au JW, Berman RF, Jin LW, Schumann C, Hagerman PJ, Hagerman RJ. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Molecular Autism. 2: 2. PMID 21303513 DOI: 10.1186/2040-2392-2-2 |
0.328 |
|
| 2011 |
Jacquemont S, Curie A, des Portes V, Torrioli MG, Berry-Kravis E, Hagerman RJ, Ramos FJ, Cornish K, He Y, Paulding C, Neri G, Chen F, Hadjikhani N, Martinet D, Meyer J, et al. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Science Translational Medicine. 3: 64ra1. PMID 21209411 DOI: 10.1126/Scitranslmed.3001708 |
0.309 |
|
| 2011 |
Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. The Journal of Clinical Psychiatry. 72: 175-82. PMID 20816038 DOI: 10.4088/Jcp.09M05407Blu |
0.702 |
|
| 2011 |
Hashimoto R, Backer KC, Tassone F, Hagerman RJ, Rivera SM. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Journal of Psychiatric Research. 45: 36-43. PMID 20537351 DOI: 10.1016/J.Jpsychires.2010.04.030 |
0.304 |
|
| 2011 |
Hagerman RJ, Turk J, Schneider A, Hagerman PJ. Fragile X syndrome: Medical and genetic aspects The Sage Handbook of Developmental Disorders. 43-56. DOI: 10.4135/9781446201107.n4 |
0.546 |
|
| 2010 |
Hagerman R, Hoem G, Hagerman P. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Molecular Autism. 1: 12. PMID 20858229 DOI: 10.1186/2040-2392-1-12 |
0.399 |
|
| 2010 |
Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJ. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. Journal of Clinical Psychopharmacology. 30: 642-4. PMID 20841969 DOI: 10.1097/Jcp.0B013E3181F1D10A |
0.639 |
|
| 2010 |
Chonchaiya W, Tassone F, Ashwood P, Hessl D, Schneider A, Campos L, Nguyen DV, Hagerman RJ. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Human Genetics. 128: 539-48. PMID 20809278 DOI: 10.1007/S00439-010-0882-8 |
0.664 |
|
| 2010 |
Utari A, Chonchaiya W, Rivera SM, Schneider A, Hagerman RJ, Faradz SM, Ethell IM, Nguyen DV. Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. American Journal On Intellectual and Developmental Disabilities. 115: 433-43. PMID 20687826 DOI: 10.1352/1944-7558-115.5.433 |
0.587 |
|
| 2010 |
Wang LW, Berry-Kravis E, Hagerman RJ. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 264-74. PMID 20643379 DOI: 10.1016/j.nurt.2010.05.005 |
0.351 |
|
| 2010 |
Utari A, Adams E, Berry-Kravis E, Chavez A, Scaggs F, Ngotran L, Boyd A, Hessl D, Gane LW, Tassone F, Tartaglia N, Leehey MA, Hagerman RJ. Aging in fragile X syndrome. Journal of Neurodevelopmental Disorders. 2: 70-76. PMID 20585378 DOI: 10.1007/s11689-010-9047-2 |
0.623 |
|
| 2010 |
Ross-Inta C, Omanska-Klusek A, Wong S, Barrow C, Garcia-Arocena D, Iwahashi C, Berry-Kravis E, Hagerman RJ, Hagerman PJ, Giulivi C. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. The Biochemical Journal. 429: 545-52. PMID 20513237 DOI: 10.1042/Bj20091960 |
0.362 |
|
| 2010 |
Paul R, Pessah IN, Gane L, Ono M, Hagerman PJ, Brunberg JA, Tassone F, Bourgeois JA, Adams PE, Nguyen DV, Hagerman R. Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins. Neurotoxicology. 31: 399-402. PMID 20466021 DOI: 10.1016/J.Neuro.2010.04.002 |
0.308 |
|
| 2010 |
Stevens L, Tartaglia N, Hagerman R, Riley K. Clinical report: a male with Down syndrome, fragile X syndrome, and autism. Journal of Developmental and Behavioral Pediatrics : Jdbp. 31: 333-7. PMID 20453578 DOI: 10.1097/DBP.0b013e3181d5aa56 |
0.404 |
|
| 2010 |
Olichney JM, Chan S, Wong LM, Schneider A, Seritan A, Niese A, Yang JC, Laird K, Teichholtz S, Khan S, Tassone F, Hagerman R. Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome. Brain : a Journal of Neurology. 133: 1438-50. PMID 20410144 DOI: 10.1093/Brain/Awq077 |
0.594 |
|
| 2010 |
Ashwood P, Nguyen DV, Hessl D, Hagerman RJ, Tassone F. Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis? Brain, Behavior, and Immunity. 24: 898-902. PMID 20102735 DOI: 10.1016/J.Bbi.2010.01.008 |
0.627 |
|
| 2010 |
Garcia-Arocena D, Yang JE, Brouwer JR, Tassone F, Iwahashi C, Berry-Kravis EM, Goetz CG, Sumis AM, Zhou L, Nguyen DV, Campos L, Howell E, Ludwig A, Greco C, Willemsen R, ... Hagerman RJ, et al. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Human Molecular Genetics. 19: 299-312. PMID 19864489 DOI: 10.1093/Hmg/Ddp497 |
0.36 |
|
| 2010 |
Wang L, Hagerman R, Rathmell B, Wang P, Berry-Kravis E. Arbaclofen Treatment Is Associated with Global Behavioral Improvement in Fragile X Syndrome (FXS): Results of a Randomized, Controlled Phase 2 Trial Journal of Developmental and Behavioral Pediatrics. 31. DOI: 10.1097/01.Dbp.0000390253.49153.72 |
0.429 |
|
| 2010 |
Chonchaiya W, Au J, Schneider A, Harris SW, Cordeiro L, Hessl DR, Laird M, Utari A, Hagerman RJ. Increased Prevalence of Seizures, ASD, and ADHD in Boys with the Fragile X Premutation Journal of Developmental & Behavioral Pediatrics. 31: E1-E2. DOI: 10.1097/01.Dbp.0000390251.03412.6C |
0.677 |
|
| 2010 |
Berry-Kravis E, Hall DA, Leehey MA, Hagerman RJ. Treatment and management of FXTAS The Fragile X-Associated Tremor Ataxia Syndrome (Fxtas). 137-154. DOI: 10.1007/978-1-4419-5805-1_9 |
0.309 |
|
| 2009 |
Chonchaiya W, Utari A, Pereira GM, Tassone F, Hessl D, Hagerman RJ. Broad clinical involvement in a family affected by the fragile X premutation. Journal of Developmental and Behavioral Pediatrics : Jdbp. 30: 544-51. PMID 19996900 DOI: 10.1097/DBP.0b013e3181c35f25 |
0.67 |
|
| 2009 |
Chonchaiya W, Schneider A, Hagerman RJ. Fragile X: a family of disorders. Advances in Pediatrics. 56: 165-86. PMID 19968948 DOI: 10.1016/J.Yapd.2009.08.008 |
0.561 |
|
| 2009 |
Wirojanan J, Jacquemont S, Diaz R, Bacalman S, Anders TF, Hagerman RJ, Goodlin-Jones BL. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 5: 145-50. PMID 19968048 |
0.34 |
|
| 2009 |
Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, Senturk D, Schneider A, Lightbody A, Reiss AL, Hall S. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. Journal of Neurodevelopmental Disorders. 1: 33-45. PMID 19865612 DOI: 10.1007/S11689-008-9001-8 |
0.681 |
|
| 2009 |
Wilson LB, Tregellas JR, Hagerman RJ, Rogers SJ, Rojas DC. A voxel-based morphometry comparison of regional gray matter between fragile X syndrome and autism. Psychiatry Research. 174: 138-45. PMID 19853418 DOI: 10.1016/J.Pscychresns.2009.04.013 |
0.311 |
|
| 2009 |
Seritan AL, Schneider A, Olichney JM, Leehey MA, Akins RS, Hagerman RJ. Conversion disorder in women with the FMR1 premutation. American Journal of Medical Genetics. Part A. 149: 2501-6. PMID 19842197 DOI: 10.1002/Ajmg.A.33054 |
0.591 |
|
| 2009 |
Iwahashi C, Tassone F, Hagerman RJ, Yasui D, Parrott G, Nguyen D, Mayeur G, Hagerman PJ. A quantitative ELISA assay for the fragile x mental retardation 1 protein. The Journal of Molecular Diagnostics : Jmd. 11: 281-9. PMID 19460937 DOI: 10.2353/Jmoldx.2009.080118 |
0.325 |
|
| 2009 |
Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ. A review of fragile X premutation disorders: expanding the psychiatric perspective. The Journal of Clinical Psychiatry. 70: 852-62. PMID 19422761 DOI: 10.4088/Jcp.08M04476 |
0.679 |
|
| 2009 |
Brega AG, Reynolds A, Bennett RE, Leehey MA, Bounds LS, Cogswell JB, Hagerman RJ, Hagerman PJ, Grigsby J. Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS). International Journal of Geriatric Psychiatry. 24: 1101-9. PMID 19404994 DOI: 10.1002/Gps.2231 |
0.439 |
|
| 2009 |
Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, Hutchison J, Snape M, Tranfaglia M, Nguyen DV, Hagerman R. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome Journal of Medical Genetics. 46: 266-271. PMID 19126569 DOI: 10.1136/Jmg.2008.063701 |
0.691 |
|
| 2009 |
Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M. Advances in the treatment of fragile X syndrome. Pediatrics. 123: 378-90. PMID 19117905 DOI: 10.1542/peds.2008-0317 |
0.677 |
|
| 2009 |
Cornish KM, Kogan CS, Li L, Turk J, Jacquemont S, Hagerman RJ. Lifespan changes in working memory in fragile X premutation males. Brain and Cognition. 69: 551-8. PMID 19114290 DOI: 10.1016/J.Bandc.2008.11.006 |
0.311 |
|
| 2009 |
Hessl D, Berry-Kravis E, Cordeiro L, Yuhas J, Ornitz EM, Campbell A, Chruscinski E, Hervey C, Long JM, Hagerman RJ. Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 545-53. PMID 18785205 DOI: 10.1002/ajmg.b.30858 |
0.636 |
|
| 2009 |
Hall DA, Howard K, Hagerman R, Leehey MA. Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism & Related Disorders. 15: 156-9. PMID 18565783 DOI: 10.1016/j.parkreldis.2008.04.037 |
0.306 |
|
| 2009 |
Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ. A Review of Fragile X Premutation Disorders The Journal of Clinical Psychiatry. 70: 852-862. DOI: 10.4088/jcp.08r04476 |
0.629 |
|
| 2009 |
Hagerman RJ. FRAGILE X SYNDROME AND ASSOCIATED DISORDERS IN ADULTHOOD Continuum: Lifelong Learning in Neurology. 15: 32-49. DOI: 10.1212/01.CON.0000348876.24317.0e |
0.427 |
|
| 2008 |
Koldewyn K, Hessl D, Adams J, Tassone F, Hagerman PJ, Hagerman RJ, Rivera SM. Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation. Brain Imaging and Behavior. 2: 105-116. PMID 19430586 DOI: 10.1007/S11682-008-9020-9 |
0.6 |
|
| 2008 |
Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ. Autism profiles of males with fragile X syndrome. American Journal of Mental Retardation : Ajmr. 113: 427-38. PMID 19127654 DOI: 10.1352/2008.113:427-438 |
0.651 |
|
| 2008 |
Hagerman RJ, Hagerman PJ. Testing for fragile X gene mutations throughout the life span. Jama. 300: 2419-21. PMID 19033593 DOI: 10.1001/Jama.2008.684 |
0.437 |
|
| 2008 |
Hagerman RJ, Hall DA, Coffey S, Leehey M, Bourgeois J, Gould J, Zhang L, Seritan A, Berry-Kravis E, Olichney J, Miller JW, Fong AL, Carpenter R, Bodine C, Gane LW, et al. Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clinical Interventions in Aging. 3: 251-62. PMID 18686748 DOI: 10.2147/Cia.S1794 |
0.42 |
|
| 2008 |
García-Nonell C, Ratera ER, Harris S, Hessl D, Ono MY, Tartaglia N, Marvin E, Tassone F, Hagerman RJ. Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. American Journal of Medical Genetics. Part A. 146: 1911-6. PMID 18627038 DOI: 10.1002/Ajmg.A.32290 |
0.613 |
|
| 2008 |
Brega AG, Goodrich G, Bennett RE, Hessl D, Engle K, Leehey MA, Bounds LS, Paulich MJ, Hagerman RJ, Hagerman PJ, Cogswell JB, Tassone F, Reynolds A, Kooken R, Kenny M, et al. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. Journal of Clinical and Experimental Neuropsychology. 30: 853-69. PMID 18608667 DOI: 10.1080/13803390701819044 |
0.652 |
|
| 2008 |
Tartaglia N, Davis S, Hench A, Nimishakavi S, Beauregard R, Reynolds A, Fenton L, Albrecht L, Ross J, Visootsak J, Hansen R, Hagerman R. A new look at XXYY syndrome: medical and psychological features. American Journal of Medical Genetics. Part A. 146: 1509-22. PMID 18481271 DOI: 10.1002/Ajmg.A.32366 |
0.401 |
|
| 2008 |
Jenkins EC, Tassone F, Ye L, Gu H, Xi M, Velinov M, Brown WT, Hagerman RJ, Hagerman PJ. Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene. American Journal of Medical Genetics. Part A. 146: 1543-6. PMID 18478592 DOI: 10.1002/Ajmg.A.32342 |
0.311 |
|
| 2008 |
Cornish KM, Li L, Kogan CS, Jacquemont S, Turk J, Dalton A, Hagerman RJ, Hagerman PJ. Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 44: 628-36. PMID 18472033 DOI: 10.1016/J.Cortex.2006.11.002 |
0.411 |
|
| 2008 |
Wirojanan J, Angkustsiri K, Tassone F, Gane LW, Hagerman RJ. A girl with fragile X premutation from sperm donation. American Journal of Medical Genetics. Part A. 888-92. PMID 18286596 DOI: 10.1002/ajmg.a.31876 |
0.362 |
|
| 2008 |
Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology. 22: 48-60. PMID 18211155 DOI: 10.1037/0894-4105.22.1.48 |
0.63 |
|
| 2008 |
Amiri K, Hagerman RJ, Hagerman PJ. Fragile X-associated tremor/ataxia syndrome: an aging face of the fragile X gene. Archives of Neurology. 65: 19-25. PMID 18195136 DOI: 10.1001/Archneurol.2007.30 |
0.424 |
|
| 2008 |
Kogan CS, Turk J, Hagerman RJ, Cornish KM. Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 859-72. PMID 18165971 DOI: 10.1002/ajmg.b.30685 |
0.428 |
|
| 2008 |
Hessl D, Tassone F, Cordeiro L, Koldewyn K, McCormick C, Green C, Wegelin J, Yuhas J, Hagerman RJ. Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder. Journal of Autism and Developmental Disorders. 38: 184-9. PMID 17340199 DOI: 10.1007/S10803-007-0365-5 |
0.596 |
|
| 2008 |
Hagerman R. Commonalities in the neurobiology between autism and fragile X Journal of Intellectual Disability Research. 52: 817-817. DOI: 10.1111/J.1365-2788.2008.01120_5.X |
0.427 |
|
| 2008 |
Hagerman R, Berry-Kravis E, Hessl D, Coffey S, Schneider A, Nguyen D, Hervey C, Hutchison J, Snape M. Trial of fenobam, an mGluR5 antagonist, in adults with Fragile X Syndrome Journal of Intellectual Disability Research. 52: 814-814. DOI: 10.1111/J.1365-2788.2008.01119_9.X |
0.703 |
|
| 2007 |
Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, ... Hagerman RJ, et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2018-30, quiz 2140. PMID 17618523 DOI: 10.1002/Mds.21493 |
0.412 |
|
| 2007 |
Bourgeois JA, Cogswell JB, Hessl D, Zhang L, Ono MY, Tassone F, Farzin F, Brunberg JA, Grigsby J, Hagerman RJ. Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. General Hospital Psychiatry. 29: 349-56. PMID 17591512 DOI: 10.1016/J.Genhosppsych.2007.03.003 |
0.658 |
|
| 2007 |
McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, Sherman S, Nelson LM, Berry-Kravis E, Hessl D, Chiu S, Street N, Vatave A, Hagerman RJ. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. Journal of Genetic Counseling. 16: 593-606. PMID 17497108 DOI: 10.1007/s10897-007-9099-y |
0.668 |
|
| 2007 |
Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, Li L, Hagerman RJ, Hagerman PJ. CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 566-9. PMID 17427188 DOI: 10.1002/Ajmg.B.30482 |
0.335 |
|
| 2007 |
Solomon M, Hessl D, Chiu S, Hagerman R, Hendren R. A genetic etiology of pervasive developmental disorder guides treatment. The American Journal of Psychiatry. 164: 575-80. PMID 17403969 DOI: 10.1176/Ajp.2007.164.4.575 |
0.598 |
|
| 2007 |
Greco CM, Soontrapornchai K, Wirojanan J, Gould JE, Hagerman PJ, Hagerman RJ. Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome. The Journal of Urology. 177: 1434-7. PMID 17382748 DOI: 10.1016/J.Juro.2006.11.097 |
0.456 |
|
| 2007 |
Chiu S, Wegelin JA, Blank J, Jenkins M, Day J, Hessl D, Tassone F, Hagerman R. Early acceleration of head circumference in children with fragile x syndrome and autism. Journal of Developmental and Behavioral Pediatrics : Jdbp. 28: 31-5. PMID 17353729 DOI: 10.1097/01.Dbp.0000257518.60083.2D |
0.64 |
|
| 2007 |
Leehey MA, Hagerman RJ, Hagerman PJ. Fragile X syndrome vs fragile X-associated tremor/ataxia syndrome. Archives of Neurology. 64: 289; author reply 28. PMID 17296852 DOI: 10.1001/Archneur.64.2.289-A |
0.397 |
|
| 2007 |
Hagerman PJ, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome--an older face of the fragile X gene. Nature Clinical Practice. Neurology. 3: 107-12. PMID 17279084 DOI: 10.1038/Ncpneuro0373 |
0.305 |
|
| 2007 |
Grigsby J, Brega AG, Leehey MA, Goodrich GK, Jacquemont S, Loesch DZ, Cogswell JB, Epstein J, Wilson R, Jardini T, Gould E, Bennett RE, Hessl D, Cohen S, Cook K, ... ... Hagerman RJ, et al. Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 645-50. PMID 17266074 DOI: 10.1002/Mds.21359 |
0.628 |
|
| 2007 |
Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, Hagerman PJ, Hagerman RJ. Amygdala dysfunction in men with the fragile X premutation. Brain : a Journal of Neurology. 130: 404-16. PMID 17166860 DOI: 10.1093/Brain/Awl338 |
0.638 |
|
| 2007 |
Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. The Lancet. Neurology. 6: 45-55. PMID 17166801 DOI: 10.1016/S1474-4422(06)70676-7 |
0.443 |
|
| 2007 |
Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. Neuropathic features in fragile X premutation carriers. American Journal of Medical Genetics. Part A. 143: 19-26. PMID 17152065 DOI: 10.1002/Ajmg.A.31559 |
0.399 |
|
| 2007 |
Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, et al. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 203-6. PMID 17133502 DOI: 10.1002/Mds.21252 |
0.634 |
|
| 2007 |
Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, Bulhak-Paterson D, Tassone F, Taylor AK, Hessl D, Hagerman R, Huggins RM. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neuroscience and Biobehavioral Reviews. 31: 315-26. PMID 17097142 DOI: 10.1016/J.Neubiorev.2006.09.007 |
0.667 |
|
| 2007 |
Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. The FMR1 premutation and reproduction. Fertility and Sterility. 87: 456-65. PMID 17074338 DOI: 10.1016/j.fertnstert.2006.09.004 |
0.398 |
|
| 2007 |
Wirojanan J, Yuhas J, Harris S, Cook K, Goodlin-Jones BL, Ono M, Hagerman RJ. ARE TICS IN FRAGILE X SYNDROME RELATED TO AUTISM? Journal of Investigative Medicine. 55: S82. DOI: 10.1097/00042871-200701010-00045 |
0.399 |
|
| 2006 |
Grigsby J, Leehey MA, Jacquemont S, Brunberg JA, Hagerman RJ, Wilson R, Epstein JH, Greco CM, Tassone F, Hagerman PJ. Cognitive impairment in a 65-year-old male with the fragile X-associated tremor-ataxia syndrome (FXTAS). Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 19: 165-71. PMID 16957495 DOI: 10.1097/01.Wnn.0000213906.57148.01 |
0.333 |
|
| 2006 |
Grigsby J, Brega AG, Jacquemont S, Loesch DZ, Leehey MA, Goodrich GK, Hagerman RJ, Epstein J, Wilson R, Cogswell JB, Jardini T, Tassone F, Hagerman PJ. Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). Journal of the Neurological Sciences. 248: 227-33. PMID 16780889 DOI: 10.1016/J.Jns.2006.05.016 |
0.327 |
|
| 2006 |
Jacquemont S, Leehey MA, Hagerman RJ, Beckett LA, Hagerman PJ. Size bias of fragile X premutation alleles in late-onset movement disorders. Journal of Medical Genetics. 43: 804-9. PMID 16723388 DOI: 10.1136/Jmg.2006.042374 |
0.385 |
|
| 2006 |
Bourgeois JA, Farzin F, Brunberg JA, Tassone F, Hagerman P, Zhang L, Hessl D, Hagerman R. Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 171-7. PMID 16720793 DOI: 10.1176/Appi.Neuropsych.18.2.171 |
0.688 |
|
| 2006 |
Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. Journal of Developmental and Behavioral Pediatrics : Jdbp. 27: S137-44. PMID 16685180 DOI: 10.1097/00004703-200604002-00012 |
0.635 |
|
| 2006 |
Hagerman RJ. Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. Journal of Developmental and Behavioral Pediatrics : Jdbp. 27: 63-74. PMID 16511373 DOI: 10.1097/00004703-200602000-00012 |
0.43 |
|
| 2006 |
Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. The Journal of Clinical Psychiatry. 67: 87-94. PMID 16426093 |
0.389 |
|
| 2006 |
Davis S, Tartaglia N, Reynolds A, Hansen R, Hagerman R. 72 Comparison Of Behavioral Phenotypes Of Xxy Versus Xxyy Syndrome. Journal of Investigative Medicine. 54. DOI: 10.2310/6650.2005.X0004.71 |
0.422 |
|
| 2006 |
Davis S, Tartaglia N, Reynolds A, Hansen R, Hagerman R. 43 Comparison Of Behavioral Phenotypes Of Xxy Versus Xxyy Syndrome. Journal of Investigative Medicine. 54. DOI: 10.2310/6650.2005.X0004.42 |
0.422 |
|
| 2006 |
Hagerman RJ, Hagerman PJ. Fragile X syndrome and fragile X-associated tremor/ataxia syndrome Genetic Instabilities and Neurological Diseases, Second Edition. 165-174. DOI: 10.1016/B978-012369462-1/50011-9 |
0.396 |
|
| 2005 |
Hagerman RJ, Ono MY, Hagerman PJ. Recent advances in fragile X: a model for autism and neurodegeneration. Current Opinion in Psychiatry. 18: 490-6. PMID 16639106 DOI: 10.1097/01.Yco.0000179485.39520.B0 |
0.395 |
|
| 2005 |
Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, ... ... Hagerman RJ, et al. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 139: 115-21. PMID 16184602 DOI: 10.1002/Ajmg.B.30241 |
0.615 |
|
| 2005 |
Mothersead PK, Conrad K, Hagerman RJ, Greco CM, Hessl D, Tassone F. GRAND ROUNDS: an atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated tremor/ataxia syndrome. Applied Neuropsychology. 12: 169-78. PMID 16131344 DOI: 10.1207/S15324826An1203_7 |
0.665 |
|
| 2005 |
Schwartz PH, Tassone F, Greco CM, Nethercott HE, Ziaeian B, Hagerman RJ, Hagerman PJ. Neural progenitor cells from an adult patient with fragile X syndrome. Bmc Medical Genetics. 6: 2. PMID 15649335 DOI: 10.1186/1471-2350-6-2 |
0.348 |
|
| 2005 |
Goodlin-Jones BL, Tassone F, Gane LW, Hagerman RJ. Autistic spectrum disorder and the fragile X premutation. Journal of Developmental and Behavioral Pediatrics : Jdbp. 25: 392-8. PMID 15613987 DOI: 10.1097/00004703-200412000-00002 |
0.397 |
|
| 2005 |
Harris S, Goodlin-Jones B, Nowicki S, Bacalman S, Tassone F, Hagerman R. Autism Profiles of Young Males with Fragile X Syndrome Journal of Developmental & Behavioral Pediatrics. 26: 464. DOI: 10.1097/00004703-200512000-00026 |
0.389 |
|
| 2004 |
Moore CJ, Daly EM, Tassone F, Tysoe C, Schmitz N, Ng V, Chitnis X, McGuire P, Suckling J, Davies KE, Hagerman RJ, Hagerman PJ, Murphy KC, Murphy DG. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain : a Journal of Neurology. 127: 2672-81. PMID 15483045 DOI: 10.1093/Brain/Awh256 |
0.316 |
|
| 2004 |
Moore CJ, Daly EM, Schmitz N, Tassone F, Tysoe C, Hagerman RJ, Hagerman PJ, Morris RG, Murphy KC, Murphy DG. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia. 42: 1934-47. PMID 15381024 DOI: 10.1016/J.Neuropsychologia.2004.05.002 |
0.357 |
|
| 2004 |
Cornish KM, Turk J, Wilding J, Sudhalter V, Munir F, Kooy F, Hagerman R. Annotation: Deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 45: 1042-53. PMID 15257661 DOI: 10.1111/J.1469-7610.2004.T01-1-00297.X |
0.365 |
|
| 2004 |
Philofsky A, Hepburn SL, Hayes A, Hagerman R, Rogers SJ. Linguistic and cognitive functioning and autism symptoms in young children with fragile X syndrome. American Journal of Mental Retardation : Ajmr. 109: 208-18. PMID 15072521 DOI: 10.1352/0895-8017(2004)109<208:Lacfaa>2.0.Co;2 |
0.336 |
|
| 2004 |
Hagerman PJ, Hagerman RJ. The Fragile-X Premutation: A Maturing Perspective American Journal of Human Genetics. 74: 805-816. PMID 15052536 DOI: 10.1086/386296 |
0.445 |
|
| 2004 |
Loesch DZ, Huggins RM, Hagerman RJ. Phenotypic variation and FMRP levels in fragile X. Mental Retardation and Developmental Disabilities Research Reviews. 10: 31-41. PMID 14994286 DOI: 10.1002/MRDD.20006 |
0.323 |
|
| 2004 |
Hagerman PJ, Hagerman RJ. Fragile X-Associated, Tremor/Ataxia Syndrome (FXTAS) Mental Retardation and Developmental Disabilities Research Reviews. 10: 25-30. PMID 14994285 DOI: 10.1002/Mrdd.20005 |
0.453 |
|
| 2004 |
Crnic LS, Hagerman R. Preface: fragile X syndrome: frontiers of understanding gene-brain-behavior relationships. Mental Retardation and Developmental Disabilities Research Reviews. 10: 1-2. PMID 14994281 DOI: 10.1002/Mrdd.20001 |
0.416 |
|
| 2004 |
Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. Jama. 291: 460-9. PMID 14747503 DOI: 10.1001/Jama.291.4.460 |
0.38 |
|
| 2003 |
Loesch DZ, Bui QM, Grigsby J, Butler E, Epstein J, Huggins RM, Taylor AK, Hagerman RJ. Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X. Neuropsychology. 17: 646-57. PMID 14599277 DOI: 10.1037/0894-4105.17.4.646 |
0.375 |
|
| 2003 |
Berry-Kravis E, Lewin F, Wuu J, Leehey M, Hagerman R, Hagerman P, Goetz CG. Tremor and ataxia in fragile X premutation carriers: Blinded videotape study Annals of Neurology. 53: 616-623. PMID 12730995 DOI: 10.1002/Ana.10522 |
0.367 |
|
| 2003 |
Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. American Journal of Human Genetics. 72: 869-78. PMID 12638084 DOI: 10.1086/374321 |
0.432 |
|
| 2003 |
Leehey MA, Munhoz RP, Lang AE, Brunberg JA, Grigsby J, Greco C, Jacquemont S, Tassone F, Lozano AM, Hagerman PJ, Hagerman RJ. The fragile X premutation presenting as essential tremor. Archives of Neurology. 60: 117-21. PMID 12533098 DOI: 10.1001/Archneur.60.1.117 |
0.359 |
|
| 2003 |
Loesch DZ, Huggins RM, Bui QM, Epstein JL, Taylor AK, Hagerman RJ. Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile x males and females assessed by robust pedigree analysis. Journal of Developmental and Behavioral Pediatrics : Jdbp. 23: 416-23. PMID 12476071 DOI: 10.1097/00004703-200212000-00004 |
0.35 |
|
| 2002 |
Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. Ajnr. American Journal of Neuroradiology. 23: 1757-66. PMID 12427636 |
0.309 |
|
| 2002 |
Hagerman RJ, Hagerman PJ. The fragile X premutation: Into the phenotypic fold Current Opinion in Genetics and Development. 12: 278-283. PMID 12076670 DOI: 10.1016/S0959-437X(02)00299-X |
0.363 |
|
| 2002 |
Leehey MA, Hagerman RJ, Landau WM, Grigsby J, Tassone F, Hagerman PJ. Tremor/ataxia syndrome in fragile X carrier males Movement Disorders. 17: 744-745. DOI: 10.1002/Mds.10208 |
0.385 |
|
| 2001 |
Rogers SJ, Wehner EA, Hagerman R. The behavioral phenotype in fragile X: Symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders Journal of Developmental and Behavioral Pediatrics. 22: 409-417. PMID 11773805 DOI: 10.1097/00004703-200112000-00008 |
0.427 |
|
| 1999 |
Holden JJ, Percy M, Allingham-Hawkins D, Brown WT, Chiurazzi P, Fisch G, Gane L, Gunter C, Hagerman R, Jenkins EC, Kooy RF, Lubs HA, Murray A, Neri G, Schwartz C, et al. Eighth International workshop on the fragile X syndrome and X-linked mental retardation, August 16-22, 1997. American Journal of Medical Genetics. 83: 221-36. PMID 10208154 DOI: 10.1002/(Sici)1096-8628(19990402)83:4<221::Aid-Ajmg1>3.0.Co;2-K |
0.474 |
|
| 1999 |
Harris SW, Hagerman RJ. Fragile X syndrome: new developments Current Opinion in Psychiatry. 12: 573-578. DOI: 10.1097/00001504-199909000-00008 |
0.351 |
|
| 1998 |
Taylor RJ, Scharfenaker S, OʼConnor R, Lampe M, Kovach T, Hills J, Tassone F, Taylor AK, Hagerman RJ. Severe Language Impairment in Fragile X Syndrome Journal of Developmental & Behavioral Pediatrics. 19: 381. DOI: 10.1097/00004703-199810000-00017 |
0.311 |
|
| 1997 |
Hagerman R. Fragile X: treatment of hyperactivity. Pediatrics. 99: 753. PMID 9157389 DOI: 10.1542/Peds.99.5.753 |
0.393 |
|
| 1996 |
Tranebjaerg L, Lubs HA, Borghgraef M, Brown WT, Fisch G, Fryns J.- P, Hagerman R, Jacobs PA, Mandel JL, Mulley J, Oostra B, Schwartz C, Sherman S, Willard H, Willems P. Seventh International Workshop on the Fragile X and X-linked mental retardation American Journal of Medical Genetics. 64: 1-14. PMID 8826442 DOI: 10.1002/(Sici)1096-8628(19960712)64:1<1::Aid-Ajmg1>3.0.Co;2-Z |
0.447 |
|
| 1996 |
Dykens E, Ort S, Cohen I, Finucane B, Spiridigliozzi G, Lachiewicz A, Reiss A, Freund L, Hagerman R, O'Connor R. Trajectories and profiles of adaptive behavior in males with fragile X syndrome: multicenter studies. Journal of Autism and Developmental Disorders. 26: 287-301. PMID 8792261 DOI: 10.1007/Bf02172475 |
0.395 |
|
| 1995 |
Schapiro MB, Murphy DG, Hagerman RJ, Azari NP, Alexander GE, Miezejeski CM, Hinton VJ, Horwitz B, Haxby JV, Kumar A. Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolism. American Journal of Medical Genetics. 60: 480-93. PMID 8825884 DOI: 10.1002/Ajmg.1320600603 |
0.384 |
|
| 1995 |
Hagerman RJ. Molecular and clinical correlations in fragile X syndrome Mental Retardation and Developmental Disabilities Research Reviews. 1: 276-280. DOI: 10.1002/MRDD.1410010408 |
0.34 |
|
| 1994 |
Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JJ, Stevenson RE. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. American Journal of Medical Genetics. 51: 400-2. PMID 7943006 DOI: 10.1002/Ajmg.1320510419 |
0.401 |
|
| 1994 |
Sutherland GR, Brown WT, Hagerman R, Jenkins E, Lubs H, Mandel JL, Nelson D, Neri G, Partington MW, Richards RI. Sixth international workshop on the fragile X and X-linked mental retardation. American Journal of Medical Genetics. 51: 281-93. PMID 7942989 DOI: 10.1002/Ajmg.1320510402 |
0.425 |
|
| 1993 |
Hagerman R. Clinical conundrums in fragile X syndrome. Nature Genetics. 1: 157-8. PMID 1303227 DOI: 10.1038/NG0692-157 |
0.368 |
|
| 1992 |
Freund LS, Reiss AL, Hagerman R, Vinogradov S. Chromosome fragility and psychopathology in obligate female carriers of the fragile X chromosome. Archives of General Psychiatry. 49: 54-60. PMID 1728251 DOI: 10.1001/ARCHPSYC.1992.01820010054007 |
0.321 |
|
| 1992 |
Reiss AL, Cianchetti C, Cohen IL, DeVries B, Hagerman R, Hinton V, Froster U, Lachiewicz A, Mazzocco M, Sobesky W. Brief screening questionnaire for determining affected state in fragile X syndrome: a consensus recommendation. American Journal of Medical Genetics. 43: 61-4. PMID 1605236 DOI: 10.1002/Ajmg.1320430109 |
0.464 |
|
| 1992 |
Mandel JL, Hagerman R, Froster U, Brown WT, Jenkins EC, Jacobs P, Turner G, Lubs H, Neri G. Fifth International Workshop on the Fragile X and X-Linked Mental Retardation American Journal of Medical Genetics. 43: 5-27. PMID 1605233 DOI: 10.1002/ajmg.1320430104 |
0.312 |
|
| 1992 |
Snow K, Doud L, Hagerman R, Hull C, Hirst MC, Davies KE, Thibodeau SL. Analysis of mutations at the fragile X locus using the DNA probe Ox1.9. American Journal of Medical Genetics. 43: 244-54. PMID 1605198 DOI: 10.1002/Ajmg.1320430139 |
0.393 |
|
| 1991 |
Brown WT, Jenkins E, Neri G, Lubs H, Shapiro LR, Davies KE, Sherman S, Hagerman R, Laird C. Conference report: Fourth International Workshop on the fragile X and X-linked mental retardation. American Journal of Medical Genetics. 38: 158-72. PMID 1673296 DOI: 10.1002/ajmg.1320380202 |
0.317 |
|
| 1988 |
Reiss AL, Hagerman RJ, Vinogradov S, Abrams M, King RJ. Psychiatric disability in female carriers of the fragile X chromosome. Archives of General Psychiatry. 45: 25-30. PMID 3337608 DOI: 10.1001/archpsyc.1988.01800250029005 |
0.414 |
|
| 1988 |
Hagerman R, Berry R, Jackson AW, Campbell J, Smith ACM, McGavran L. Institutional Screening for the Fragile X Syndrome American Journal of Diseases of Children. 142: 1216-1221. PMID 3177330 DOI: 10.1001/Archpedi.1988.02150110094028 |
0.467 |
|
| 1988 |
Brown WT, Gross A, Chan C, Jenkins EC, Mandel JL, Oberlé I, Arveiler B, Novelli G, Thibodeau S, Hagerman R, Summers K, Turner G, White BN, Mulligan L, Forster-Gibson C, et al. Multilocus analysis of the fragile X syndrome Human Genetics. 78: 201-205. PMID 3162224 DOI: 10.1007/Bf00291662 |
0.397 |
|
| 1988 |
Waldstein G, Hagerman R. Aortic hypoplasia and cardiac valvular abnormalities in a boy with fragile X syndrome. American Journal of Medical Genetics. 30: 83-98. PMID 2972207 DOI: 10.1002/Ajmg.1320300107 |
0.447 |
|
| 1988 |
Peretz B, Ever-Hadani P, Casamassimo P, Eidelman E, Shellhart C, Hagerman R. Crown size asymmetry in males with fra (X) or Martin-Bell syndrome. American Journal of Medical Genetics. 30: 185-90. PMID 2972204 DOI: 10.1002/ajmg.1320300117 |
0.343 |
|
| 1987 |
Chudley AE, de von Flindt R, Hagerman RJ. Cognitive variability in the fragile X syndrome. American Journal of Medical Genetics. 28: 13-5. PMID 3674106 DOI: 10.1002/ajmg.1320280103 |
0.325 |
|
| 1986 |
Shellhart WC, Casamassimo PS, Hagerman RJ, Belanger GK. Oral findings in fragile X syndrome. American Journal of Medical Genetics. 23: 179-87. PMID 3953646 DOI: 10.1002/ajmg.1320230112 |
0.326 |
|
| 1985 |
Hagerman R, Kemper M, Hudson M. Learning disabilities and attentional problems in boys with the fragile X syndrome. American Journal of Diseases of Children (1960). 139: 674-8. PMID 4014089 DOI: 10.1001/Archpedi.1985.02140090036021 |
0.473 |
|
| Show low-probability matches. |